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ABSTRACT 
 
Janet B. Pelletier. APPRAISAL OF UNCERTAINTY WHILE WAITING FOR A KIDNEY 
TRANSPLANT (Under the direction of Dr. Martha Alligood). College of Nursing, November 
2012. 
  
This study tested a middle range nursing theory to better understand the experience of 
uncertainty in deceased-donor kidney transplant candidates with a goal of identifying ways to 
improve the care of persons by nurses as they await kidney transplant. From Mishel’s 
Reconceptualized Uncertainty in Illness Theory a middle range theory was developed that 
proposes that deceased-donor kidney transplant candidates show growth through uncertainty as 
Mishel describes, waiting time for a transplant is related to the level of uncertainty, and growth 
through uncertainty is related to both waiting time and level of uncertainty in deceased-donor 
kidney transplant candidates. A descriptive survey research design was used to address two 
research questions: Do deceased-donor kidney transplant candidates experience growth through 
uncertainty as Mishel’s Reconceptualized Uncertainty in Illness Theory proposes? What are the 
relationships among waiting time, level of uncertainty, and growth through uncertainty for 
deceased-donor kidney transplant candidates? 
The study sample was adults who:  volunteered to participate, were English speaking and 
were actively waiting for a deceased-donor kidney transplant. A convenience sample of 134 
deceased-donor kidney transplant candidates was recruited through dialysis clinics, an electronic 
message posted on a National Kidney Foundation message board, and a mailing to deceased- 
donor transplant candidates registered with a transplant center.  A strength of the study was the 
sample size and the sub-sample of 103 African American persons.  
Mishel’s Uncertainty in Illness Scale-Community version was used to measure 
uncertainty and the Growth through Uncertainty Scale quantified growth through uncertainty. 
 The relationships among waiting time, level of uncertainty and growth through uncertainty were 
analyzed using Pearson correlation coefficients. The independent-groups t-test was used to 
compare those waiting above and below the national median time to transplant.  
Of the proposed relationships, a significant positive relationship between waiting time 
and growth through uncertainty was found. The findings provide further description of the 
uncertainty experienced by transplant candidates who are waiting for a deceased-donor kidney.   
The present study also supports the concept of growth through uncertainty when sustained 
uncertainty is present, contributing to the development of Mishel’s Reconceptualized 
Uncertainty in Illness Theory.  
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CHAPTER I: STATEMENT OF THE PROBLEM 
Waiting is both a stationary and a dynamic phenomenon (Irvin, 2001), an act that entails 
being inactive. Although waiting implies anticipation or expectation, the timeframe is often 
indeterminate and unknown. While all patients may be waiting, the wait for an organ transplant 
might be considered an extreme form of waiting (Brown, Sorrell, McClaren, & Creswell, 2006). 
The wait for a transplant may be prolonged and the outcome is unpredictable.  
  Due to the shortage of organs, there are over 114,000 people awaiting organ transplant 
(United States Department of Health and Human Services, Health Resources and Services 
Administration, Organ Procurement and Transplantation Network, 2012) with the average wait 
for an organ increasing as the demand intensifies. Waiting for a transplant is not an orderly 
process. There is not a first-come first-served list. Rather, the selection of the candidate for 
transplant involves consideration of numerous factors besides the availability of an organ. The 
waiting period can be demanding, stressful, and life threatening, but also means the chance for a 
better physical, mental, and social quality of life (Franke et al., 2000). Being listed for a 
transplant brings its own stressors and an uncertain trajectory (McDermott, Hardy, & McCurry, 
2010). Transplant candidates are vulnerable to both isolation and depression (Brown et al., 
2006). Since the waiting time is indeterminate, the stress experienced by both the patient and 
family during the waiting period may increase and cannot be eliminated (Irvin, 2001).  
With lengthening waiting times for organs and an ever increasing number of people on 
the waiting list for organ transplants, more understanding of the experience of waiting for a 
transplant is needed. While there is research examining physiological issues in organ transplant, 
research on the experience and perceptions of individuals who are waiting for a transplant is 
lacking. Although, a majority of nurses may not have a direct role in the pre-transplant or 
transplant process, many nurses have indirect experience with organ transplants. Individuals 
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awaiting transplant have concomitant health conditions that are usually addressed by nurses in 
settings other than a transplant center.  More understanding of the concerns and needs of this 
population is needed to help guide nursing interactions with transplant candidates and improve 
their care. 
The pre-transplant period is a liminal time, an uncertain and ambiguous time (Molzahn, 
Bruce, & Shields, 2008). Brown et al. (2006) describe the pre-transplant time as a paradox. 
Transplant candidates plan for the future and prepare for death during the unpredictable wait for 
a transplant. Escalating health problems may hasten a transplant or make a candidate ineligible 
for transplant. As the waiting time increases, the risk of dying while waiting for a transplant 
increases (Zhang, Kumar, Ramcharan, & Reisin, 2004). Being sicker creates a greater medical 
need for a transplant, but may also prevent a transplant from occurring or affect survival 
following transplant.  
Different responses to waiting for a transplant have been observed in previous studies for 
different pre-transplant waiting times (Brown et al., 2006; Jonsen, Athlin, & Suhr, 2000; Weems 
& Patterson, 1989). Boredom, frustration and discouragement were noted by liver transplant 
candidates as waiting time increased (Brown et al., 2006). Changes in coping strategies were 
needed when the waiting period became longer than anticipated (Weems & Patterson, 1989). 
Waiting for a transplant allows time to prepare for and focus on the potential positive outcomes 
of a transplant, however, when the wait is considered too long, waiting may be viewed 
negatively (Jonsen et al., 2000). In a study of patients awaiting heart transplantation, Evangelista 
et al. (2005) found quality of life changed over time. Quality of life improved with increasing 
length of waiting time up until two years. However, if the patients had not undergone 
transplantation after two years, quality of life declined. 
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Qualitative studies have identified uncertainty as a key characteristic of the experience of 
waiting for a transplant (Baker & McWilliam, 2003; Brown et al., 2006; Liddle & Innes, 2005; 
Weems & Patterson, 1989). Mishel (1990) defines uncertainty as the inability to determine the 
meaning of illness-related events and/or to accurately predict outcomes due to the lack of 
sufficient cues. McCormick (2002) proposed that uncertainty is present when one does not know 
how long it will be until the unpredictability of the situation is resolved. Pervasive uncertainty is 
present in the pre-transplant period and is a major concern for individuals awaiting transplant 
(Weems & Patterson, 1989). Interacting with the transplant team, not knowing when or if an 
organ will become available, and not being able to influence the outcome are sources of 
uncertainty for transplant candidates.  
Uncertainty is a significant source of stress in chronic illness (Anema, Johnson, Zeller, 
Fogg, & Zetterlund, 2009) and is viewed as a major feature of the illness experience (Babrow, 
Kasch, & Ford, 1998). Uncertainty can be regarded as a natural component of an illness 
situation, prevalent when unpredictability is ongoing (McCormick, 2002). Waiting for a 
transplant may involve prolonged, continual uncertainty associated with the unpredictable and 
indeterminate wait for the transplant. With transplants, what the future holds is uncertain (Mishel 
& Murdaugh, 1987). Transplant candidates have no influence over when or if they will receive a 
transplant, which affects their experience of uncertainty (Penrod, 2001).  
 Individuals assign meaning to uncertainty and determine if it is viewed as positive or 
negative (Neville, 2003). The appraisal of uncertainty may be different at different times during 
an illness (Brashers et al., 2003). Various factors influence the appraisal of uncertainty as a threat 
or an opportunity. Bailey and Nielsen (1993) found that when the level of uncertainty is higher, 
uncertainty is more likely appraised as a danger or threat. They suggested that living longer with 
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uncertainty may be associated with a positive appraisal of uncertainty, but the length of time 
since a diagnosis may also not be associated with how uncertainty is viewed. Some individuals 
with chronic illness may tend to view continued uncertainty as positive if the alternative is 
confirmation of the downward trajectory of an illness (Mishel, 1990). If, as these findings 
suggest, the appraisal of uncertainty is individual and dynamic, then uncertainty may change 
throughout the wait for a transplant.  
Mishel (1990) proposed that reconstruction and reframing occur in response to the 
uncertainty of chronic illness. She suggested that uncertainty, even if prolonged, can  be accepted 
and integrated into one’s life and leads to a new view of life (Mishel, 1990). Others have 
suggested that living through uncertainty may evoke personal growth (Penrod, 2007). If, or how 
transplant candidates integrate the uncertainty of waiting for a transplant into a new view of life 
is not known. With lengthening waiting times for organs and an ever increasing number of 
people waiting for organ transplants, more understanding of the experience of waiting for a 
transplant is needed. While uncertainty is described in qualitative research for transplant 
candidates, further description of the experience of uncertainty in those waiting for a transplant 
provides both greater insight into the needs of transplant candidates and additional understanding 
of the experience of uncertainty in illness.  
The majority of people waiting for organ transplant, over 98,000, are awaiting a kidney 
transplant (United States Department of Health and Human Services, Health Resources and 
Services Administration, Organ Procurement and Transplantation Network, 2012). Most adults 
waiting for a kidney transplant have end-stage renal disease (ESRD) with kidney function that is 
so low that dialysis or kidney transplantation is required. Risk factors for ESRD include age  
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> 60 years, African American ethnicity, low socioeconomic status, diabetes, hypertension, 
autoimmune disorders and systemic infection. Diabetes and hypertension are responsible for the 
majority of ESRD (Yee, 2008). Renal transplantation offers a greater chance of survival for 
individuals with progressive renal disease (Yee, 2008).  
An increasing number of people are being diagnosed with ESRD; however, the 
percentage of dialysis patients who receive a transplant within three years of registering on the 
transplant wait list has declined (Wolfe, 2005). There are two types of kidney transplants. In one 
type, the kidney is from a living donor, and in the other type, the kidney is from a deceased 
donor. The focus of this study is on individuals awaiting deceased-donor kidney transplants. The 
average wait for a donor kidney depends on geographic region, blood type, tissue type and the 
presence of antibodies. More than half of the transplant candidates have been waiting over two 
years for a transplant and approximately 12 % of the transplant candidates have been waiting for 
transplant for more than five years (United States Department of Health and Human Services, 
Health Resources and Services Administration, Organ Procurement and Transplantation 
Network, 2012). 
Both physical and psychosocial challenges confront individuals during the wait for a 
transplant (Hutchinson, 2005). As waiting time increases, transplant candidates are becoming 
sicker and the chances of survival following transplant may be lessened (Neuberger & James, 
1999). A longer time on dialysis is linked to less positive outcomes for persons receiving renal 
transplants (Meier-Kriesche & Kaplan, 2002). Transplant candidates may become concerned 
about how deteriorating health will complicate their prospective transplant.  
Differences in waiting times and complications exist for heart, renal, liver and lung 
transplant candidates (Kurz & Cavanaugh, 2001). The experience of uncertainty within each of 
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these groups may have similarities, but there may be differences that influence the responses of 
the transplant candidate to stressors during the pre-transplant period. Stoeckle (1993) found that 
adults awaiting kidney transplant had a low to moderate level of uncertainty during the pre-
transplant period. Moderate levels of uncertainty were also found in another study of individuals 
awaiting deceased donor kidney transplant (Russell & Brown, 2002). No other research 
specifically focused on uncertainty in individuals awaiting kidney transplants was found in the 
literature.  
Theoretical Framework 
Mishel’s (1990) Reconceptualized Uncertainty in Illness Theory provided the framework 
for this study.  The theory was developed to accommodate responses to uncertainty over time in 
people with chronic conditions (Bailey & Stewart, 2010). Mishel (1981) originally developed the 
Uncertainty in Illness Theory to investigate the role of uncertainty in the experience of stress 
associated with various acute illnesses. Mishel (1999) maintained that uncertainty in chronic 
illness might involve more areas of life than uncertainty in acute illness. Mishel’s 
reconceptualization expanded her original theory to focus on integration of uncertainty into one’s 
life when living with continual uncertainty rather than the focus of the earlier theory on reducing 
uncertainty (Mishel, 1999).  
The antecedents to uncertainty in both the original and the reconceptualized theory are 
cognitive capacity, stimuli frame and structure providers (Bailey & Stewart, 2010). Figure 1 
depicts the antecedents of uncertainty according to Mishel. Cognitive capacity refers to the 
ability of a person to process information (Wallace, 2005). The stimuli frame includes symptom 
pattern, which encompasses characteristics about the number, frequency, intensity and duration 
of symptoms (Mishel & Braden, 1988). Event familiarity, which develops over time, is also part  
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Figure 1. Antecedents of uncertainty based on Mishel’s uncertainty in illness theory. 
 
 
Note. (Adapted from Mishel & Braden, 1988; Wallace, 2005).  
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of the stimuli frame. Unfamiliarity with an event or situation is more likely to be associated with 
greater uncertainty (Mishel & Braden, 1988). According to Mishel, structure providers include 
education, social support and credible authority (Bailey & Stewart, 2010; Mishel & Braden, 
1988). The latter refers to confidence in health care providers. Education directly impacts 
uncertainty by influencing how information can be assimilated (Mishel & Braden, 1988). 
Uncertainty is also influenced by social support; the individuals interpretation of uncertain illness 
related events is affirmed or rejected by supportive others (Mishel & Braden, 1988).  
In research based on Mishel’s theory, nurses, as structure providers, have a significant 
role in helping a chronically ill individual view uncertainty as an opportunity (Bailey, Mishel, 
Belyea, Stewart, & Mohler, 2004; Bailey & Stewart, 2010). According to Mishel’s theory, 
structure providers directly influence uncertainty by assisting the patient to determine the 
familiarity of events and the pattern of their symptoms (Mishel & Braden, 1988). Affirmation of 
views about a situation by structure providers who provide social support reduces uncertainty 
about illness and treatment (Mishel & Braden, 1988). Mishel (1990) emphasizes that structure 
providers, specifically social support figures, are influential in helping the patient acquire a 
probabilistic view of uncertainty.  
 Mishel revised her original theory after noting the response to uncertainty evolving from 
disorganization to a new life view in patients with chronic illness (Bailey & Stewart, 2010; 
Mishel, 1999). A proposition within this theory is that a new state may evolve when a person has 
to live with enduring uncertainty. Mishel’s reconceptualized model of the evolving nature of the 
experience of uncertainty is shown in Figure 2. Mishel reasoned that in long-term uncertainty, an 
individual might begin to more positively evaluate uncertainty as the uncertainty is incorporated 
into  
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Figure 2. Mishel’s reconceptualized model of uncertainty in chronic illness. 
 
 
Note. The evolving nature of the experience of uncertainty according to Mishel’s 
Reconceptualized Uncertainty in Illness Theory with reorganization and repatterning leading to a 
new view of life. [Printed with electronic permission of Dr. Donald Bailey Jr., September 30, 
2010 (see Appendix B)].  
UNCERTAINTY Opportunity Danger 
Time 
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a person’s life and is accepted as normal (Mishel, 1999). Life experience, physiologic status and 
social resources influence the new orientation to uncertainty (Mishel, 1990). In the 
Reconceptualized Uncertainty in Illness Theory the concepts of self-organization and 
probabilistic thinking are added (Mishel & Clayton, 2008). Mishel and Clayton (2008) describe 
self-organization as the new sense of order that results from integrating and accepting continuous 
uncertainty and it is through probabilistic thinking that the expectation of certainty and 
predictability is abandoned. In the Reconceptualized Uncertainty in Illness Theory, enduring 
uncertainty that is initially viewed as danger is reappraised over time and through repatterning 
and reorganization a new view of life can emerge (Mishel & Clayton, 2008). 
When waiting for an organ transplant, what the future holds is uncertain. Mishel’s 
reconceptualized theory supports the premise that perspectives of uncertainty evolve and change 
over time in kidney transplant candidates. Uncertainty is the force leading to a new perspective 
on life (Mishel, 1999). Mishel’s reconceptualized theory provides a framework for the appraisal 
of uncertainty in individuals experiencing continual uncertainty and for considering the outcome 
of sustained uncertainy, including the opportunity for growth through uncertainy. The 
Reconceptualized Uncertainty in Illness Theory proposes the appraisal of uncertainty changes 
over time when an individual experiences the prolonged uncertainty associated with chronic 
illness. Based on Mishel’s Reconceptualized Uncertainty in Illness Theory: 
• If persons experience prolonged uncertainty in chronic illness, their appraisal of 
uncertainty evolves and changes over time (Mishel, 1990). 
• If appraisal of uncertainty evolves and changes, when persons experience prolonged 
uncertainty in chronic illness, growth through uncertainty can occur and a new view 
of life may develop (Mishel, 1990). 
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Since qualitative studies have identified uncertainty as a theme when waiting for a transplant 
(Baker & McWilliam, 2003; Brown et al., 2006; Liddle & Innes, 2005; Mishel & Murdaugh, 
1987; Pelletier-Hibbert & Sohi, 2001; Weems & Patterson, 1989), the following was proposed: 
 1. Transplant candidates experience growth through uncertainty.  
 
2. There are relationships among waiting time, level of uncertainty, and growth  
    through uncertainty in transplant candidates. 
A middle range theory of the relationship among waiting time, level of uncertainty, and 
growth through uncertainty was proposed and tested in this study. It was proposed that: 
1. Deceased-donor kidney transplant candidates show growth through uncertainty as 
     Mishel describes.  
2. The level of uncertainty is related to waiting time in deceased-donor kidney transplant  
     candidates. 
3. Growth through uncertainty is related to both the waiting time and the level of  
     uncertainty experienced by deceased-donor kidney transplant candidates. 
The proposed relationships are depicted in Figure 3.   
Therefore, the use of Mishel’s Reconceptualized Uncertainty in Illness Theory as a 
framework for research about the experience of uncertainty during the wait for a deceased-donor 
kidney transplant, guides the description of the uncertainty as well as possible growth through 
uncertainty for kidney transplant candidates. This description of the experience of uncertainty in 
kidney transplant candidates increases the understanding of the experience of waiting for an 
organ transplant which leads to improved nursing care for this population.  
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Waiting for a Kidney Transplant 
 
 
                                                         Uncertainty 
 
                                                      
      Waiting        ?            Level of 
                                                      Time      Uncertainty 
                                                                        
                                                                     ?                ?    
                                                                           
                                                                  Growth Through 
                                                                  Uncertainty 
 
 
 
Figure 3. Middle range theory of the experience of uncertainty while waiting for a kidney 
transplant. 
 
Note. Visual model of the proposed relationships among waiting time, level of uncertainty, and 
growth through uncertainty in the middle-range theory developed by the researcher and tested in 
the current study.   
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Purpose 
Since limited research has explored the pre-transplant period and qualitative studies have 
identified uncertainty as a hallmark of the experience of waiting for an organ transplant, the 
purpose of this study was to test a middle range theory proposing that deceased-donor kidney 
transplant candidates show growth through uncertainty as described by Mishel (1990). The 
middle range theory further proposed that waiting time for a transplant is related to the level of 
uncertainty in deceased-donor kidney transplant candidates and growth through uncertainty is 
related to both waiting time and level of uncertainty. The relationships among waiting time, level 
of uncertainty and growth through uncertainty were proposed and explored to provide further 
understanding of the experience of uncertainty in deceased-donor kidney transplant candidates.  
Research Questions 
 1. Do deceased-donor kidney transplant candidates experience growth through      
     uncertainty as Mishel’s Reconceptualized Uncertainty in Illness Theory proposes? 
 2. What are the relationships among waiting time, level of uncertainty and growth  
      Through uncertainty in deceased-donor kidney transplant candidates? 
Definition of Terms for this Study 
 End-Stage Renal Disease (ESRD): According to the National Kidney Foundation Kidney 
Disease Outcome Quality Initiative [KDOQI] (2012),  ESRD occurs when there are signs and 
symptoms of kidney failure that necessitate the initiation of treatment by renal replacement 
therapy (dialysis or transplant) in order to sustain life.  
 Growth through Uncertainty:  Based on Mishel’s (1990) Reconceptualized Uncertainty 
in Illness Theory, when uncertainty is integrated into one’s life, a new view of life can evolve, 
which is measured by Growth Through Uncertainty Scale (GTUS) (Bailey et al., 2004).   
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 Dialysis:  Dialysis replaces some of the functions of the kidney when the kidney is no 
longer working or in ESRD. There are two are two types of dialysis, hemodialysis and peritoneal 
dialysis. In end stage kidney failure the need for dialysis is permanent or a transplant is needed 
(KDOQI, 2012). 
 Pre-transplant Period:  The period of time beginning from being placed on the wait list 
for a kidney transplant until a transplant is received.   
 Transplant Candidate:  An adult, age 18 or over, who is listed for a deceased-donor 
kidney transplant [officially registered with the United Network for Organ Sharing (UNOS)] and 
is active on the waiting list. 
 Uncertainty:  A component of illness, defined as the “the inability to determine the 
meaning of illness-related events, occurring when the decision maker is unable to assign definite 
value to objects or events and/or is unable to predict outcomes accurately because sufficient cues 
are lacking” (Mishel, 1990, p. 256). 
 Level of uncertainty: The total score that the transplant candidate receives on the Mishel 
Uncertainty in Illness Scale-Community version (Mishel, 1997).  
 Waiting time:  The amount of time, in months, the transplant candidate has been listed for 
a transplant. 
Limitations 
 This study included individuals waiting for a deceased-donor kidney transplants in a 
specific region of the United States and is representative of the region. The findings may not be 
applicable to kidney transplant candidates in other regions nor to candidates for other types of 
organ transplants.  
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Delimitations 
A delimitation in this study was the convenience sample. Only individuals who were 
English speaking were included in the study. Most of the sample of adult deceased-donor kidney 
transplant candidates was from a single transplant center in the southeastern United States. The 
majority of the sample was accessed by a mailing coordinated by the transplant center. 
Participants volunteered to participate in this study. Although all participants were actively 
waiting for a deceased-donor kidney transplant, participants were not specifically selected based 
on waiting time for this preliminary test of the middle range theory. Transplant candidates who 
had been waiting longer for a kidney are less represented in the sample.  
Significance of the Study 
 This study is significant in several ways. The experience of uncertainty during the pre-
transplant period, which is a theme in previous qualitative studies, was explored in this study. 
While uncertainty is described in qualitative research for transplant candidates, and has been 
measured in transplant candidates in a limited number of studies in the literature, the experience 
of uncertainty while waiting for a transplant needs additional description and definition. This 
study was designed to contribute to the understanding of the nature of uncertainty during the pre-
transplant period. Transplant candidates are a vulnerable population (Brown et al., 2006) with 
longer waits for donor organs prolonging the uncertainty of the pre-transplant period. With more 
people needing organ transplants and the increasing waiting time for organs, further description 
of the experience of waiting for a transplant may help identify patient needs and guide research 
to develop nursing interventions. Using Mishel’s Reconceptualized Uncertainty in Illness Theory 
(Mishel, 1990), the level of uncertainty experienced by deceased-donor kidney transplant 
candidates was described. Mishel’s Reconceptualized Uncertainty in Illness Theory addresses 
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prolonged uncertainty in chronic illness. This study was designed to further describe the nature 
of uncertainty in the deceased-donor kidney transplant candidate and to determine if the 
appraisal of the continual uncertainty associated with the wait for a transplant and the outcomes 
of uncertainty for deceased-donor kidney transplant candidates are explained by Mishel’s theory. 
The results of this research expand nursing knowledge through contributing to further 
understanding of the experience of uncertainty while waiting for a transplant and the 
development of the theory of uncertainty in illness. Within Mishel’s Uncertainty in Illness 
Theory, nurses are structure providers, credible authorities who can influence a patient’s 
appraisal of uncertainty. Through supportive communication, nurses can develop the capacity of 
transplant candidates to view uncertainty as an opportunity (Santacroce, Asmus, Kadan-Lottick, 
& Grey, 2010). More knowledge of the uncertainty experienced by the transplant candidate 
supports improved, more comprehensive nursing care for this population. Understanding 
uncertainty increases understanding of patient responses to illness and is important for changing 
responses to unavoidable uncertainty (Kang, 2009). The study provides a basis for further study 
related to nursing care of transplant candidates as they navigate the pre-transplant period.  
Summary 
 The wait for an organ transplant is an uncertain time. Physical and psychosocial 
challenges confront transplant candidates. Waiting times are increasing as more people wait for a 
limited number of organs. Greater understanding of the experience of waiting for a transplant is 
needed to help guide nursing care for transplant candidates.  
 Mishel’s Reconceptualized Uncertainty in Illness Theory provided the theoretical 
framework for this study. Mishel’s theory proposes that in long term uncertainty, an individual 
may more positively evaluate uncertainty and incorporate uncertainty into a new view of life, 
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which Mishel describes as growth. From Mishel’s theory a middle range nursing theory was 
proposed and tested in this study to further describe the experience of uncertainty for deceased-
donor kidney transplant candidates and describe the relationship among growth through 
uncertainty, waiting time, and level of uncertainty for these transplant candidates.  
  
 
CHAPTER II: REVIEW OF THE LITERATURE 
Mishel (1990) has proposed that growth through uncertainty can occur when prolonged 
uncertainty is experienced in chronic illness. The purpose of this study was to test a middle range 
theory that proposes that deceased-donor kidney transplant candidates show growth through 
uncertainty as described by Mishel (1990). The middle range theory tested in this study further 
proposes that waiting time for a transplant is related to the level of uncertainty in deceased-donor 
kidney transplant candidates and growth through uncertainty is related to both waiting time and 
the level of uncertainty. The relationships among waiting time, level of uncertainty and growth 
through uncertainty were explored.  
The first section of this review of the literature focuses on research related to the 
experience of waiting for a transplant. The next section discusses research addressing the 
experience of uncertainty in individuals with chronic illness. This discussion of the literature on 
uncertainty focuses on research based on Mishel’s theory of uncertainty in illness that explores 
sustained uncertainty, concluding with a discussion of research that has used Mishel’s measure 
of Growth through Uncertainty in Illness.  
Waiting for a Transplant 
When an individual needs an organ transplant, there is a wait involved. The description of 
the health status of the transplant candidate by Brown et al. (2006) provides insight into the 
experience of waiting for a transplant. The transplant candidate is “neither healthy nor ill, just 
‘pre-transplant’” (Brown et al., 2006, p. 132). The future is the goal. Brown et al. completed a 
phenomenological study to explore the meaning that people with liver failure ascribe to the 
experience of waiting for a transplant. The participants in the study had been waiting for a 
transplant between 4 months and 8 years. Changes in response to waiting were noted as waiting 
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time increased. When first listed for transplant, the participants described experiencing a feeling 
of relief and gratitude at being placed on the list. As waiting time increased, discouragement, 
frustration and boredom was described. There was both a fear that the transplant would never 
occur as well as fear of the impending surgery.  
Brown et al. (2006) described a difference in the experience of time for the transplant 
candidate. For the transplant candidates in their study, time had a different meaning with times 
experienced as “until transplant...and after transplant” (Brown et al., 2006, p. 130). While 
waiting for a transplant, a diagnosis is known, treatment of underlying conditions continues, but 
the timing and occurrence of the transplant is uncertain. Transformation was one of the themes 
that emerged in the study. Since being listed for a transplant, participants described a new self 
emerging, but there was also resistance to the possible changes related to waiting for a transplant. 
Participants developed coping strategies to deal with the uncertainty, the waiting and the 
differences in how they experienced time. The authors note that all the participants in the study 
were white and suggest that different cultural beliefs about time and illness may lead to different 
results. The results of their study suggest that further description of the relationship between 
waiting time and the response to waiting, including the experience of uncertainty, will provide 
more understanding of the challenges of the pre-transplant period.  
  A participant in a qualitative study of lung transplant candidates by Macdonald (2006) 
described the pre-transplant period as, “I’m not really living, I’m just getting by” (p. 570). 
Macdonald examined the lived experience of patients with cystic fibrosis and their carers as they 
coped with chronic illness while waiting for a lung transplant. Semi-structured interviews were 
completed with eight patients and five carers. The theme that emerged for the transplant waiting 
period was “life in limbo” (Macdonald, 2006). The experience of transplantation was 
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characterized by uncertainty (Macdonald, 2006). Limitations of this study included the small 
sample size, which made it difficult to achieve data saturation (Macdonald, 2006), inclusion of 
post-transplant candidates in the study, which brought a retrospective slant to the description of 
the pre-transplant period, and data from transplant candidates and carers were combined. The 
present study included only individuals who are waiting for a transplant and specifically 
describes the experience of uncertainty during this phase of the experience of transplantation.  
 The overarching pattern in a qualitative study exploring the experiences of patients with 
ESRD who were having hemodialysis was “Waiting for a kidney transplant” (Moran, Scott, & 
Darbyshire, 2011). The study was conducted in the Republic of Ireland with 16 participants. The 
participants described “living in hope” of a transplant (Moran et al., 2011). Participants seemed 
to interpret the average waiting time for a transplant as the actual time they would wait and over 
time the hope turned to uncertainty if the transplant did not occur by an expected date (Moran et 
al., 2011). The experience of “life on hold” was also described by participants in this study with 
life centered on waiting for a transplant, which, according to the authors, suggests an inability to 
project forward into possibilities in the future. The authors propose that the participants are 
“enduring,” which implies focusing on the present and blocking out the past and the future. Their 
findings supported exploring the relationship between uncertainty and waiting time for a 
transplant in the current study and determining whether or not individuals experience growth 
through uncertainty when they are “enduring” life on hold. 
Transplant candidates may experience feelings of uncertainty about whether or not a 
transplant would improve their quality of life (Weems & Patterson, 1989). Weems and Patterson 
(1989) explored the experience of waiting for a transplant through interviews with 14 
hospitalized patients ten days after they had received a kidney transplant. For these participants, 
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uncertainty pervaded the waiting period. One transplant candidate likened the experience of 
waiting to “walking in the dark” (Weems & Patterson, 1989). The transplant candidate makes a 
choice of continuing to wait or just going on with life as it is now. The uncertainty was related to 
when they might receive a kidney and, later in the waiting period, wondering if they would ever 
receive a transplant. Ways of coping and sustaining hope varied among transplant candidates and 
individuals modified their coping strategies as they faced ongoing uncertainty. This was a 
retrospective study exploring the experience of waiting for a transplant after the participants had 
a kidney transplant rather than during the pre-transplant period was proposed in this study. 
Further exploration of the experiences of transplant candidates while waiting for a transplant can 
provide a more comprehensive understanding of the pre-transplant time. 
Quality of life during the pre-transplant period is also described in the literature. In a 
study of quality of life in patients referred for heart transplant, Evangelista et al. (2005) found an 
improvement in physical health and depression scores over time, which was attributed to patients 
adjusting to the knowledge that they needed a heart transplant and finding ways to cope with 
their condition. However, when comparing patients who had not undergone transplantation at 
two years to the patients who had received a transplant and those who were determined to be too 
well for transplant, the transplant candidates were more depressed and had worse physical and 
mental health (Evangelista et al., 2005). The study was limited by the small sample size with 
only 13 subjects in the pre-transplant group at the time of the two-year follow-up, but results of 
this study suggest that waiting time may affect perceptions while waiting for a transplant. 
Corruble et al. (2010) found that patients who were waiting for a kidney transplant showed an 
increase in anxiety and depression from the time they were added to the waiting list and when 
they were assessed two years later. The 390 patients in this study were assessed for anxiety and 
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depression at the time of inclusion on the waiting list for a kidney transplant, and 12 months and 
24 months later, unless they had a transplant, and three months after transplantation (Corruble et 
al., 2010). The authors suggest that transplant candidates may progressively lose hope and 
experience an increasing fear of not receiving a transplant. 
Molzahn et al. (2008) maintained the experience of living between the promise of 
prolonged life and the threat of death is not well understood. The authors used narrative inquiry 
of secondary data, consisting of 100 different narratives, in a study exploring the liminal 
experiences of people with ESRD. Transplantation was viewed as a “ticket to freedom” and the 
chance to lead a normal life. For a few people, dialysis was just a necessary in-between phase 
with the goal of a transplant, while others described a less restrictive attitude toward dialysis 
coexisting with the possibility of transplant. The authors suggested further exploration of 
whether comfort in liminal space is affected by how one deals with uncertainty. The responses of 
transplant candidates to possibly prolonged liminal experiences are influenced by their appraisal 
of and response to uncertainty. Their study lends strong support for the present study, which is 
focused on the nature of uncertainty in a liminal period. Further understanding of the experience 
of uncertainty while waiting for a transplant can lead to knowledge that nurses and other health 
care providers need to improve their capacity to comfort transplant candidates during this liminal 
time. 
Uncertainty has been found to vary considerably from pre-transplant to post-transplant 
among patients and their partners in an exploratory study of the process of adjustment to kidney 
transplantation (Starzomski & Hilton, 2000). The level of uncertainty was one of the measures 
used to compare adjustment to kidney transplantation with and without a period of dialysis. 
Uncertainty was described as moderate to low with a significant decrease in uncertainty post-
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transplant. Consistent areas of uncertainty were the patient’s ability to function and concern 
about the stability of the patient’s condition. Starzomski and Hilton (2000) recommended further 
research to account for changes that may occur while waiting for a transplant. This present study 
addresses that recommendation.  
There have been a limited number of qualitative studies that describe the experiences of 
family members and support persons during the pre-transplant period, which offer a broader 
view of the experience of waiting for a transplant (Mishel & Murdaugh, 1987; Myaskovsky et 
al., 2004; Pelletier-Hibbert & Sohi, 2001; Saxe-Braithwaite & Chapman, 1992). This family and 
support person literature was reviewed but is not discussed further here since it is beyond the 
purpose of the present study.  
Uncertainty about the future and waiting for a donor organ were identified as two of the 
ten worst stressors for heart transplant candidates (Jalowiec, Grady, & White-Williams, 1994). 
The worst stressor was finding out that they needed a transplant. The majority of the population 
in this study of 175 heart transplant candidates had been told about the need for a heart transplant 
within the three months prior to the study. The authors suggested that the wait for a compatible 
organ might rank higher as a stressor with longer waiting times. Cupples, Nolan, Augustine and 
Kynoch (1998) also found that waiting for a donor heart was a consistent stressor but not one of 
the biggest stressors for heart transplant candidates. Stressors were measured at three, six, nine 
and twelve months after being listed for transplant. Stressors fluctuated throughout this time 
period. These authors recommended description of stressors beyond a one-year waiting period 
since waiting times for transplants are increasing.  
How transplant candidates manage uncertainty affects their quality of life (Scott, Martin, 
Stone, & Brashers, 2011). Most of the participants in a qualitative study of individuals who had 
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received or were waiting for a kidney, liver, heart, or pancreas described significant uncertainty 
related to their illness, identity and relationships (Scott et al., 2011). The authors of the study 
examined the role of social support in uncertainty management for transplant patients. The study 
included eight pre-transplant participants who had been waiting between 2 and 36 months for an 
organ. The results of the study found that the participants interact with others with a goal of 
managing uncertainty and while social support may facilitate uncertainty management, at other 
times social support may interfere with uncertainty management. Scott et al. (2011) suggest that 
uncertainty experiences likely differ by organ type and support for uncertainty management may 
differ before and after transplantation. The present study focused on the uncertainty during the 
time before transplant for deceased-donor kidney transplant candidates providing a more specific 
description of uncertainty during the wait for a transplant.  
The qualitative studies that have described the experience of waiting for a transplant for 
the transplant candidate provide insight about what it means to wait for a transplant. Some 
studies described different experiences associated with different waiting times. While there is 
limited research in the literature that focuses on the pre-transplant period and the wait for a 
transplant, uncertainty emerges as a common theme in the studies. The wait for an organ is one 
of the stressors identified in the research for heart transplant candidates. The pre-transplant 
period has been described as a time of pervasive uncertainty with the unpredictability of when or 
if an organ will become available for transplant as one of the primary sources of uncertainty. The 
research also suggests that differences in length of waiting time are associated with differences in 
the experience of waiting for a transplant and response to waiting for a transplant. This literature 
is supportive of the need for this study to describe the experience of uncertainty and explore the 
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relationship between waiting time and the experience of uncertainty during the pre-transplant 
period.  
Uncertainty in Chronic Illness 
Mishel’s (1990) Reconceptualized Uncertainty in Illness Theory, which addresses the 
experience of sustained uncertainty, may provide information about the prolonged uncertainty of 
the pre-transplant period. She has found that uncertainty in individuals with chronic conditions 
fluctuates over time (Mishel, 1990). Mishel (1990) maintains that aside from physiological 
status, factors influencing an individual’s orientation to uncertainty include life experiences, 
social support and health care providers. Studies on the experience of sustained uncertainty in 
transplant candidates are limited; therefore this section of the literature review focuses primarily 
on research on sustained uncertainty in chronic illness that uses Mishel’s theory. 
One qualitative study applied Mishel’s theory of uncertainty in illness. Martin, Stone, 
Scott and Brashers (2010) identified forms of uncertainty across the “transplantation trajectory.”    
Eight of the participants were pre-transplant and were waiting for a heart, kidney or liver 
transplant with waiting times ranging from 2 to 36 months. Overlapping medical, personal and 
social forms of uncertainty were identified for these participants. Participants reported 
experiencing medical uncertainty related to insufficient information about diagnosis, making 
decisions about transplantation, concerns about not getting a transplant and uncertainty related to 
unclear information about medical procedures such as dialysis (Martin et al., 2010). Personal 
uncertainty pre-transplant was about the meaning of life, role changes, and unclear financial 
consequences related to transplant costs. Questioning from others about the transplant process 
and unclear relational implications were social forms of uncertainty in the pre-transplant period. 
The causes of uncertainty pre-transplant identified in the study go beyond medical issues, which 
 26 
 
lend support to Mishel's theory of uncertainty in illness (Martin et al., 2010). Further research to 
identify how transplant patients evaluate and manage uncertainty was recommended and the 
current study addresses that recommendation.  
Uncertainty is present among cancer survivors because of the risk of relapse and the 
possibility of late effects of treatment regimens (Santacroce & Lee, 2006). Uncertainty has been 
negatively correlated with quality of life in breast cancer survivors (Sammarco, 2003). 
Sammarco (2003) investigated the relationship among perceived social support, uncertainty and 
quality of life in 103 breast cancer survivors who were older than 50 years. Uncertainty was 
measured using Mishel’s Uncertainty in Illness Scale-Community form. The experience of 
uncertainty was positively correlated with age and was also higher in women who had other 
diseases that were associated with a decreased quality of life. The time since diagnosis of breast 
cancer ranged from one to 24 years. The relationship of length of time since diagnosis and 
uncertainty was not specifically reported.  
The experience of long-term uncertainty in cancer patients was also the focus of research 
by Bailey, Wallace and Mishel (2007). Mishel’s Reconceptualized Uncertainty in Illness Theory 
was the organizing framework for analysis in a qualitative descriptive study of men undergoing 
watchful waiting for prostate cancer. Watchful waiting was defined by the authors as 
surveillance followed by treatment if the cancer progresses and causes bothersome symptoms. 
The men lived with uncertainty about whether their disease would remain stable or progress 
(Bailey et al., 2007). A defining characteristic of the uncertainty experienced by the participants 
was that there were few symptoms that they could monitor to give them information about the 
progression of their disease. Their health care providers could not predict how the cancer might 
progress. The men in the study had been living with prostate cancer for four to twelve months. 
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The decision of watchful waiting rather than treatment caused persistent worry, stress and 
uncertainty for some of the men. Others viewed watchful waiting as an opportunity to use a 
variety of activities, such as work or self-care strategies, to manage their uncertainty. Although 
the results of this study are not generalizable, there may be similarities to the experience of 
waiting for a transplant. Transplant candidates must also respond to the unpredictable 
progression of their disease while they wait for a transplant. 
In another study involving watchful waiting, Bailey et al. (2009) examined the experience 
of uncertainty for patients with chronic hepatitis C (CHC). The cross-sectional study used the 
Mishel Uncertainty in Illness Scale (MUIS) to explore the relationship between illness 
uncertainty and fatigue, pain, depressive symptoms, co-morbidity and quality of life. Up to 50% 
of patients with CHC are not actively undergoing treatment. Instead they are undergoing a 
“watchful waiting” protocol which can be “observation, expectant management, active 
monitoring or deferred treatment” (Bailey et al., 2009, p. 138).” Results indicated that ambiguity 
or unclear bodily cues about the state of one’s illness (Bailey et al., 2009), is a key construct of 
the uncertainty experienced by patients with CHC who are managing their disease with their 
healthcare provider through watching and monitoring their condition (Bailey et al., 2009). 
Similarly, transplant candidates are waiting, but qualitative research suggests that not knowing 
when or if a transplant would occur and not knowing the outcome of a transplant are the primary 
sources of uncertainty for transplant candidates. Bailey et al. maintained that identifying the 
constructs of uncertainty is essential to understanding the experience of patients and for 
developing interventions for uncertainty management that can be targeted to specific patient 
populations. Further description of the uncertainty experienced by transplant candidates is 
needed before interventions can be developed to help transplant candidates manage uncertainty.  
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Bailey and Nielsen (1993) examined whether appraisal of uncertainty could be predicted 
by the length of illness and degree of uncertainty in women with rheumatoid arthritis. There is no 
cure for rheumatoid arthritis and women are unable to predict the course or progression of their 
disease (Bailey & Nielsen, 1993). The number of years since diagnosis for the subjects ranged 
from one to 42 years with a mean length of illness of 17 years. The length of illness was not 
associated with the degree of uncertainty as measured by the Mishel Uncertainty in Illness Scale, 
but women who perceived more uncertainty related to their disease, appraised the uncertainty as 
more of a danger (Bailey & Nielsen, 1993). The authors suggested that the large range of length 
of illness in the small sample might limit discerning relationships between length of illness and 
uncertainty. Research specifically describing the relationship between how long uncertainty had 
been experienced pre-transplant and level of uncertainty in transplant candidates was not 
identified in the literature.  
Two studies were found in the literature that measured uncertainty in the kidney 
transplant candidates. Stoeckle (1993) examined health-related hardiness, uncertainty, power and 
environment in 23 adults waiting for a kidney transplant. Uncertainty was measured using the 
Mishel Uncertainty in Illness Scale (MUIS) and she reported that the participants had low to 
moderate uncertainty. Relationships among the variables examined by Stoeckle included a 
negative correlation (r = -.67) between health related hardiness and uncertainty. Difficult 
environmental factors described by the participants, based on the Stoeckle Environmental 
Influence Checklist developed by the author, were related to length of time waiting for a 
transplant. A limitation of the study was the small sample size. The author recommended further 
study of the relationship among the variables, including the relationship between uncertainty and 
the length of time on the transplant waiting list. The results of this present study expand on 
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Stoeckle’s results, providing additional information on the level of uncertainty experienced by 
deceased-donor kidney transplant candidates and the relationship between uncertainty and 
waiting time.  
 The second study measuring uncertainty in kidney transplant candidates was a 
randomized controlled study by Russell and Brown (2002) examining the effects of a nursing 
intervention to provide information and social support to individuals awaiting diseased-donor 
kidney transplantation. Hope and uncertainty, measured by the MUIS, were evaluated at the 
beginning of the study and six months later. The nursing intervention consisted of monthly 
phone calls and mailings once a month for six months. One group received the intervention and 
the other did not. No change in hope or uncertainty was found in the treatment group or control 
group. A limitation was that no information was given related to the length of time the 
participants had been waiting for a transplant and the study only looked at a six month time 
period. Understanding the pre-transplant experience can be expanded by further description and 
measurement of the experience of uncertainty and the relationship between uncertainty and 
waiting time for a transplant.  
 The research described in this section examined uncertainty in individuals who were 
faced with sustained uncertainty. The majority of the people who are waiting for a transplant 
have had a long-standing chronic illness and, similar to individuals with cancer or individuals 
with CHC or rheumatoid arthritis, may appraise and reappraise uncertainty over time and, 
according to Mishel, may integrate the uncertainty into a new view of life. The experiences of 
individuals with chronic illness provide greater understanding of the experience of sustained 
uncertainty. However, the experience of sustained uncertainty may be different for the transplant 
candidate as the hoped-for transplant may lead to greater well-being. Additional research is 
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needed to determine if the experience of uncertainty while waiting for a transplant is similar to or 
different from the uncertainty experienced by individuals with chronic illness. This study is 
designed to address that need.  
Growth through Uncertainty 
Based on Mishel’s Reconceptualized Uncertainty in Illness theory, individuals who 
experience chronic uncertainty can perceive the uncertainty positively and develop a new view 
of life or growth through uncertainty (Bailey et al., 2004). This section of literature reviews 
research that measures growth through uncertainty as described by Mishel (1990). Growth 
through uncertainty occurs when continual uncertainty is integrated into a person’s life and the 
uncertainty is used to reorganize their life views (Mishel, 1990). Few studies were found in the 
published literature that explored growth through uncertainty. 
Bailey et al. (2004) explored the effects of a watchful waiting intervention on mood state, 
quality of life, cognitive reframing and growth through uncertainty in men with prostate cancer. 
The subjects were men who were being monitored rather than treated with surgery or radiation 
(watchful waiting) and had been followed for one to 124 months. A telephone intervention was 
designed to help the men reframe the way they viewed their illness and the uncertainty 
associated with their illness. Subjects were randomly assigned to a control group or to an 
experimental group that received the intervention. The Growth through Uncertainty Scale 
(GTUS) was administered at the time of enrollment in the study and ten weeks later or about five 
weeks after the telephone intervention was completed. A significant difference in total scores on 
the GTUS was not found, but there was a significant difference on the new view of life subscale. 
Men who received the intervention had a more positive perception of their future (Bailey et al., 
2004).  
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More symptoms, higher level of education, greater religious participation, younger age 
and cognitive reframing were associated with higher levels of personal growth in breast cancer 
survivors who were 5-9 years since diagnosis (Porter et al., 2006). A negative cognitive state, 
which consisted in part of uncertainty, was associated with less personal growth. Gil et al., 
(2006) used the GTUS in an evaluation of the long-term effects of uncertainty management 
interventions for breast cancer survivors. Women in the intervention group reported stable levels 
of personal growth while women in the control group reported a decline in growth over time. 
Personal growth during the wait for a transplant has not been measured. 
The relationship of living with continual uncertainty and growth through uncertainty was 
explored in a study of 301 Taiwanese parents of children with cancer (Lin, Yeh, & Mishel, 
2010). Based on examination of a conceptual model, the results of the study demonstrated that 
parental uncertainty had no significant direct effect on growth through uncertainty. Coping 
mediated the effect of parental uncertainty on growth through uncertainty with lower uncertainty 
associated with more coping which was associated with more growth through uncertainty. The 
results of this study are specific to Taiwanese parents of children with cancer, suggesting the 
experience may be different with different illnesses and there may be cultural differences in the 
experience of growth through uncertainty. It is not known if the effect of uncertainty on growth 
through uncertainty is the same as deceased-donor kidney transplant candidates and supports 
exploration of the relationship between level of uncertainty and growth through uncertainty in 
the current study.  
The appraisal of uncertainty as opportunity in cancer survivors emphasizes the positive 
aspects of the situation. Although, Mishel’s Reconceptualized Uncertainty in Illness theory 
proposes that continual uncertainty can be integrated into a person’s life with reorganizing and 
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reframing leading to a new view of life (Mishel, 1990), no research was identified in the 
literature describing this experience in the pre-transplant population. Similar to men choosing a 
watchful waiting approach to treatment of prostate cancer or long term breast cancer survivors, 
transplant candidates may confront ongoing uncertainty if the wait for an organ is prolonged. 
Uncertainty may be different or be appraised differently at different points in time during the 
pre-transplant period. Further description of how the appraisal of uncertainty changes over time 
and whether growth through uncertainty occurs in the transplant candidate is needed for better 
understanding of the experience and to help guide the development and timing of nursing 
interventions.  
Summary 
This review of the literature has discussed the research focused on the experience of 
waiting for a transplant, uncertainty in chronic illness based on Mishel’s theory of uncertainty in 
illness, and research that has measured growth through uncertainty in illness. Uncertainty is 
described in the qualitative research as a predominant characteristic of the pre-transplant 
experience. The unpredictability of when or if an organ would become available was a primary 
source of uncertainty. The qualitative research on the experience of waiting for a transplant also 
suggests that there are changes in the response to waiting for a transplant as the wait becomes 
longer.  
Few quantitative studies have specifically looked at the experience of uncertainty while 
waiting for a transplant. Researchers have suggested that with longer waits for donor organs, 
studies should examine the experience of waiting for a transplant over longer time periods. The 
experience of continual uncertainty and appraisal of uncertainty has been studied in cancer 
survivors. Results suggested that an individual could begin to appraise uncertainty positively 
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leading to a new view of life. Further study is needed to describe the nature of uncertainty while 
waiting for a transplant, including the level of uncertainty during the pre-transplant period, 
changes in uncertainty in relation to waiting time, and the transplant candidate’s appraisal of 
uncertainty.  
Uncertainty is a theme in qualitative studies describing the experience of waiting for a 
transplant. Literature on chronic illnesses describes the nature of prolonged uncertainty, but it is 
not known if the experience of uncertainty is the same for individuals who are waiting for an 
organ transplant. This study was designed to address the need for further research by exploring 
growth through uncertainty and by describing the relationship among waiting time, level of 
uncertainty and growth through uncertainty in the deceased-donor kidney transplant candidate.  
 
  
 
CHAPTER III: METHODOLOGY 
 
The purpose of this study was to test a middle range theory that proposes that kidney 
transplant candidates show growth through uncertainty as described by Mishel (1990). The 
middle range theory further proposes that waiting time for a kidney transplant is related to the 
level of uncertainty in deceased-donor kidney transplant candidates and growth through 
uncertainty is related to both waiting time and level of uncertainty. The relationships among 
waiting time, level of uncertainty, and growth through uncertainty were explored to provide 
further understanding of the experience of uncertainty in kidney transplant candidates. This 
chapter describes the research design, the sample selection and the survey instruments used in 
this study. A description of the procedures for data collection and data analysis is given and 
measures for protection of human subjects are described.  
Research Design 
 This study used a level II correlational descriptive survey research design (Wood & Ross-
Kerr, 2006). Wood and Ross-Kerr (2006) specify that when a problem has a conceptual or 
theoretical base, a descriptive survey design is used to describe the relationship among variables 
based on correlational analysis. The theoretical base for this study is Mishel’s Reconceptualized 
Uncertainty in Illness Theory which suggests that continual uncertainty may result in personal 
growth as noted in chapters I and II. Growth through uncertainty has been demonstrated in 
chronic illness. However, the outcome of growth through uncertainty has not been tested in 
kidney transplant candidates. The middle range theory tested in this study proposes that: 
Candidates for deceased-donor kidney transplants show growth through uncertainty as described 
by Mishel, waiting time is related to the level of uncertainty in kidney transplant candidates, and 
growth through uncertainty is related to both the waiting time and the level of uncertainty 
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experienced by the kidney transplant candidate. Therefore this correlational study was designed 
to address the following research questions:     
 1. Do candidates for deceased-donor kidney transplants experience growth through   
     uncertainty as defined by Mishel?    
 2. What are the relationships among waiting time, level of uncertainty and growth  
      through uncertainty for deceased-donor transplant candidates?  
 Descriptive statistics, specifically frequencies and percentages, were used to analyze 
demographic data. The theoretically proposed relationships among waiting time, level of 
uncertainty, and growth through uncertainty were analyzed using correlation analysis. There was 
a wide range of waiting times for a transplant among participants in this study. Jalowiec et al. 
(1994), in their study of patients waiting for a heart transplant, used median waiting time to 
divide their sample into two groups to examine the effect of the transplant wait on perception of 
stressors because of a wide range of waiting times in the sample. In order to complete further 
analysis of the relationship between waiting time and level of uncertainty, and growth through 
uncertainty in the current study, the sample was divided into two groups based on national data 
for median waiting time to kidney transplant. Participants in one group had less than or equal to 
the median time to transplant and the other group consisted of the participants with a waiting 
time longer than the median time to transplant. The independent-groups t-test was used to 
compare waiting time groups in the study.  
Sample 
The study sample was drawn from adults, 18 years old or older, who were actively 
awaiting a deceased-donor kidney transplant in the southeastern United States. A convenience 
sample of the population was recruited through dialysis clinics, an electronic message posted on 
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a National Kidney Foundation message board, and a mailing to deceased-donor transplant 
candidates registered with a transplant center. Participation in the study was voluntary and 
participants had to be able to speak and read English.  
  A minimum of 45 transplant candidates from this population was needed to test the 
middle range theory proposed in this study. One hundred thirty-six transplant candidates 
volunteered to participate in the study. One participant was going to receive a living donor 
transplant and was therefore excluded from the sample.   Participants either returned the survey 
to the researcher by mail or contacted the researcher by phone to complete the survey. 
Demographic information was collected from the participants. The data collected included, age, 
gender, number of years of education, marital status, race/ethnicity, type of dialysis and the 
length of time a participant had been waiting for a kidney transplant. A copy of the demographic 
form is provided in Appendix B. The demographic characteristics of the participants are 
presented in Tables 1 and 2.  
Participants ranged in age from 25 to 73 with a mean age of 54.6 years. More participants 
were male (56%). Eighty of the participants were married. Fifty-two of the participants were 
high school graduates. Most of the participants were receiving hemodialysis (73.1%) with only 
10 participants not on dialysis. The mean waiting time for a transplant for participants in this 
study was just over three years.  
The majority of the participants were African American (76.9%). Nationally, African 
Americans comprised 36.8 % of the kidney transplant candidates in 2009 while white transplant 
candidates were 38.7 % of the total number of transplant candidates (United States Department 
of Health and Human Services, Health Resources and Services Administration, Organ  
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Table 1  
Age, Waiting Time, and Years of Education of Participants 
 
 Range M SD 
    
Age 25-73 years 54.6 9.96 
    
Waiting time for a transplant 3-180 months 37.95 28.19 
    
Years of Education 7-22 years 12.99 2.36 
Note. (n=134). 
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Table 2   
 
Type of Dialysis, Gender, Race, and Marital Status of Participants  
 
 n % 
   
Dialysis   
   
     Hemodialysis 98 73.1 
   
     Peritoneal dialysis 26 19.4 
   
     None 10 7.5 
   
Gender   
   
     Male 75 56 
   
     Female 59 44 
   
Race   
   
     African American/Black 103 76.9 
   
     White 25 18.7 
   
     Other 4 3.0 
   
Marital Status   
   
     Married 80 59.7 
   
     Divorced 13 9.7 
   
     Widowed 9 6.7 
   
     Single 28 20.9 
   
     Living with a Partner 4 3.0 
Note. (n = 134). 
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Procurement and Transplantation Network, 2012). However, the sample is representative of the 
region that the participants are from. The sample in this study was primarily from a single 
transplant center that has predominantly African Americans (76%) waiting for a transplant 
(United States Department of Health and Human Services, Health Resources and Services 
Administration, Organ Procurement and Transplantation Network, 2012) in a state where 22% of 
the population is African American (U.S. Department of Commerce United States Census 
Bureau, 2011).  
The rate of deceased-donor kidney transplants is lower among African Americans than 
whites and reflects a longer time on the transplant wait list for African Americans (Hall, Choi, 
Xu, O’Hare, & Chertow, 2011). Given the larger number of African American participants in 
this sample and the racial ethnic differences in kidney transplantation, the data for the subset of 
African American participants was analyzed separately. The demographic characteristics of the 
subset of African American participants are presented in Tables 3 and 4.  
The African American participants ranged in age from 27-72 years. Over half were 
married and more than a fourth of the participants in this subset were single. The mean number 
of years of education was 12.60; more than half of the African American participants completed 
high school or had attended college. The mean waiting time for a transplant for the African 
American participants was almost three and one-half years.  
Nationally, the median waiting time for a kidney transplant is 1297 days or 
approximately 43 months (United States Department of Health and Human Services, Health 
Resources and Services Administration, Organ Procurement and Transplantation Network, 
2012). The national median time to transplant for African Americans is 1968 days or 
approximately 66 months, and the national median time to transplant for Whites is 952 days or  
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Table 3 
Age, Waiting Time, and Years of Education of African American Participants  
 
 Range M SD 
    
Age 27-72 years 53.47 9.62 
    
Waiting time for a transplant 6-180 months 41.87 29.34 
    
Years of Education 7-17 years 12.60 1.94 
Note. (n = 103). 
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Table 4 
Type of Dialysis, Gender, and Marital Status of African American Participants  
 
 n % 
   
Dialysis   
   
     Hemodialysis 78 75.7 
   
     Peritoneal dialysis 21 20.2 
   
     None 4 3.9 
   
Gender   
   
     Male 59 57.3 
   
     Female 44 42.7 
   
Marital Status   
   
     Married 59 57.3 
   
     Divorced 10 9.7 
   
     Widowed 5 4.9 
   
     Single 26 25.2 
   
     Living with a Partner 3 2.9 
Note. (n = 103). 
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about 32 months. The independent-groups t-test was conducted to compare the relationship 
among waiting time, level of uncertainty, and growth through uncertainty in the two waiting time 
groups.  
Instruments 
Two instruments were used in this study. Mishel developed the instruments that were 
used to measure both uncertainty and growth through uncertainty and gave permission to use 
these instruments in this study (see Appendix B). Each instrument is described separately below.  
Mishel Uncertainty in Illness Scale-Community Version 
The Mishel Uncertainty in Illness Scale-Community version (MUIS-C) (see Appendix D) 
is a modification of the Mishel Uncertainty in Illness Scale (MUIS) (Mishel, 1981). The original 
scale was designed to measure uncertainty in ill, hospitalized adults. Mishel developed the MUIS 
based on a model of uncertainty in illness and after completing an exploratory study to compile 
statements from interviews with hospitalized patients that were perceived to reflect uncertainty 
(Mishel, 1981). Studies were conducted to establish validity of the scale (Mishel, 1981).  
The MUIS-C was developed for individuals who were residing in the community and 
were not hospitalized. The MUIS and the MUIS-C have been widely used in research with a 
variety of chronic illness populations (Mishel, 1997). Stoeckle (1993) and Russell and Brown 
(2002) used the MUIS to measure uncertainty in kidney transplant candidates.  
The MUIS-C has 23 items. The items are scored on a five-point Likert-type scale to 
indicate the respondent’s level of agreement with the statements. The responses on the scale are 
scored with 5 = strongly agree, 4 = agree, 3 = undecided, 2 = disagree, and 1 = strongly disagree. 
A total scale score is obtained with a higher score indicating higher levels of uncertainty. Scores 
can range from 23 to 115. Negatively worded items are reversed before coding. “I am unsure if 
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my illness is getting better or worse” and “I have a lot of questions without answers” are 
examples of items on the MUIS-C. Reliabilities for the MUIS-C, based on normative data from 
twenty studies, are in the moderate to high range (α = .74-.92) (Mishel, 1997). More recent 
studies (Bailey et al., 2009; Kazer, Bailey, Sanda, Colberg, & Kelly, 2011) have used the  
MUIS-C for men experiencing chronic uncertainty associated with active surveillance for 
prostate cancer. Bailey et al. (2009) had a reliability of α = 0.9 for the MUIS-C and Kazer et al. 
(2011) had a Cronbach alpha of 0.88. In the present study, the Cronbach alpha coefficient for the 
MUIS-C was 0.87, suggesting strong reliability of the scale for individuals waiting for a 
deceased-donor kidney transplant.  
Growth Through Uncertainty Scale 
 The Growth Through Uncertainty Scale (GTUS) (see Appendix E) measures positive 
psychological changes and the change in life view (Bailey et al., 2004; Lin et al., 2010). Mishel 
and Fleury developed the scale based on Mishel’s Reconceptualization of Uncertainty in Illness 
Theory (as cited in Bailey et al., 2004; Lin et al., 2010). The scale has 39 items that are scored on 
a 6-point Likert-type scale. Respondents may choose strongly agree, moderately agree, agree, 
undecided, disagree or strongly disagree. Examples of items are: “I have a new perspective on 
life,” and “I greet each day with more joy.” A total score is obtained with the possible scores 
ranging from 39 to 234 (Bailey et al., 2004; Lin et al., 2010). Higher scores indicate more 
psychological growth through uncertainty and changes in life view. Negatively worded items 
were reversed before coding. Mast (1998) and Porter et al. (2006) used the GTUS in research 
with breast cancer survivors with alpha coefficients for the scale of 0.94 and 0.95 respectively. In 
a study of men with prostate cancer (Bailey et al., 2004), the alpha coefficient for the GTUS was 
0.94. Cronbach alpha for the GTUS in the present study was 0.95, which indicates that the scale 
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is reliable for the sample. Construct validity has been established for the GTUS (Bailey et al. 
2004; Lin et al., 2010; Porter et al., 2006). The construct validity of the instrument is supported 
by findings of a negative correlation of the GTUS with the Profile of Mood States Scale, which 
measures mood and psychological distress (Mast, 1998). 
Procedure 
Permission to conduct the study was obtained from the East Carolina University and 
Medical Center Institutional Review Board (UMCIRB). Modifications of the procedure to recruit 
participants were necessary and the UMCIRB gave permission for each change. The UMCIRB 
study approval letters are in Appendix A. Participation in the study was voluntary. Choosing to 
participate or not participate in the study did not affect the transplant candidate’s access to care. 
Individuals were advised to direct questions regarding their health care to their health care 
providers. The instruments contained no information that personally identified the subject. The 
surveys were coded numerically and the identity of the participants was not associated with their 
responses. Individuals who wished to receive ten dollars for participating in the study either 
provided their name and mailing address by phone or completed a card with the information and 
returned it with the survey to the researcher. The data was maintained in a locked location by the 
researcher. Contact information was kept separately from the completed surveys.   
  Initially, fliers describing the research were posted in ten kidney dialysis centers and two 
clinics for kidney transplant candidates after obtaining permission verbally or by electronic mail 
from the facility. The clinics were located in both smaller, more rural communities and larger 
urban areas. The flier (see Appendix F) informed the transplant candidates that they may contact 
the researcher at a toll free number to volunteer to participate in the study and indicated that 
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participants receive ten dollars for completing the study. Business cards with the toll free number 
were attached to the flier for interested individuals to take for the contact information.  
When transplant candidates called the researcher to participate in the study, the researcher read a 
script (see Appendix G) describing the research to them. In the script, confidentiality was assured 
and the transplant candidates were informed that they may ask questions or choose to stop at any 
time. Verbal consent to participate in the study and to proceed with the questions was obtained 
from the transplant candidates. After verbal consent was obtained, the researcher asked the 
transplant candidates questions to complete the demographic form, including age to verify that 
the participants were over eighteen, and then completed the MUIS-C and GTUS with them. 
Eight participants responded to the fliers. 
In order to recruit more participants, UMCIRB permission was obtained to post a 
message on a message board on the National Kidney Foundation website. The message 
contained the same information that was given on the flier. Two individuals responded to the 
message and volunteered to participate in the study. The same procedure to obtain verbal consent 
by phone and complete the demographic form, MUIS-C and GTUS was used for these two 
participants.  
Finally, the UMCIRB gave approval for yet another way to access the population that 
required expanding the methodology to a mailed survey method. The researcher contacted a 
transplant center in the southeastern United States, who agreed to mail a packet to adult patients 
who were active on the center’s waiting list for a deceased-donor kidney. The packet contained: 
a letter from the transplant center, a letter from the researcher, the demographic form, the MUIS-
C, the GTUS, a stamped return envelope, a business card with information on how to contact the 
researcher, and a card for the name and address of the participant. The researcher prepared the 
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packets for mailing, including all postage. The staff at the transplant center identified potential 
participants, prepared address labels for 237 adult patients who were waiting for a deceased 
donor kidney transplant, and mailed the packets. The researcher did not have any knowledge of 
the names of patients or their contact information. The letter from the transplant center included 
in the mailing supported the study and assured patients of the confidentiality of their contact 
information (see Appendix H). An explanation of the nature of the study and instructions on how 
to complete and return the survey to the researcher was in the letter from the researcher (see 
Appendix I). Participants were given the option of completing a self-administered survey and 
returning the completed survey to the researcher by mail or calling the researcher at the toll free 
number to complete the survey by phone. The instructions indicated that participants would 
receive ten dollars for completing the survey. A stamped envelope addressed to the researcher 
was provided to return the survey. Verbal consent to participate in the study was obtained from 
individuals who completed the survey by phone. Consent was implied if an individual returned 
the completed survey to the researcher by mail. Two reminder postcards (see Appendix J) 
provided by the researcher were sent to all 237 patients by the transplant center approximately 2 
weeks and 4 weeks after the initial mailing. Fourteen participants chose to complete the survey 
by phone. A majority, 82%, returned the survey to the researcher by mail, making the self-
administered mailed survey the most effective method for data collection for the study 
population. The use of the mailed survey significantly increased the number of participants in the 
study and expanded the strength of the analysis of the results.  
Participants were informed that they may contact the researcher at the toll free telephone 
number and may contact the researcher’s faculty advisor with any questions regarding the 
research. A letter expressing appreciation for participating in the study, which included contact 
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information for the researcher and the faculty advisor, was sent to the participants along with the 
ten dollars (see Appendix K). Upon completion of the study, the data of each subject’s response 
to each item on the MUIS-C will be submitted to the author of the scale, Merle Mishel, as she 
requested for use of her instrument. The data will be used to add to a normative database for 
clinical populations. No other use will be made of the data submitted to Dr. Mishel. The 
participants of this study will remain anonymous. 
Summary 
This chapter provided information on the methodology used for testing the middle range 
theory proposed in this study, including the research design, which encompassed the methods 
used for analysis of data. A description of the demographic characteristics of the sample and the 
African American subset of the sample was given. Procedures for data collection, recruitment of 
participants, and measures for protection of human subjects were explained and the instruments 
that were used in this study were described. 
 
  
 
CHAPTER IV: FINDINGS 
 
The purpose of this study was to test a middle range theory that proposes that waiting 
time for a transplant is related to the level of uncertainty in deceased-donor kidney transplant 
candidates and growth through uncertainty is related to both waiting time and level of 
uncertainty. The relationships among waiting time, level of uncertainty, and growth through 
uncertainty were explored to provide further understanding of the experience of uncertainty in 
kidney transplant candidates. The research questions were: 
 1. Do deceased-donor kidney transplant candidates experience growth  
        through uncertainty as defined by Mishel? 
 2. What are the relationships among waiting time, level of uncertainty and growth  
     through uncertainty for deceased-donor kidney transplant candidates? 
Figure 3, given in Chapter I, depicts the middle range theory which was developed, proposed and 
tested by the researcher in this study based on Mishel’s Reconceptualized Uncertainty in Illness 
theory. The middle range theory proposes that:    
1. Deceased-donor kidney transplant candidates show growth through uncertainty as    
     Mishel describes.  
2. The level of uncertainty is related to waiting time in deceased-donor kidney  
    transplant candidates. 
3. Growth through uncertainty is related to both the waiting time and the level of  
    uncertainty experienced by the deceased-donor kidney transplant candidate. 
Data Analysis 
The analyses that were completed using IBM SPSS statistical software (version 19) 
included descriptive statistics. Frequencies, percentages, ranges, means and standard deviations 
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were used to describe the sample and the performance on the MUIS-C and the GTUS. The 
relationships among waiting time, level of uncertainty and growth through uncertainty were 
analyzed using Pearson correlation coefficients. One participant did not complete multiple items 
on the GTUS and was excluded from the data analysis. The independent-groups t-test was used 
to determine if individuals who had been waiting for a kidney transplant longer, based on the 
national median time to transplant, differed in level of uncertainty and growth through 
uncertainty when compared to those who had been waiting less than or equal to the median time 
to transplant. A serendipitous finding was the large number of volunteers and the high 
percentage of African Americans in the sample. Since racial ethnic differences in kidney 
transplantation have been described in the literature (Hall et al., 2011) and over 78% of the 
participants in this study were African Americans, the relationships among waiting time, level of 
uncertainty and growth through uncertainty were analyzed for the African American and White 
subsets in the sample. Among the sample, two participants did not indicate their race and four of 
the participants were from a racial group other than White or African American.  
Growth through Uncertainty 
The first research question was: Do kidney transplant candidates experience growth 
through uncertainty as Mishel’s Reconceptualized Uncertainty in Illness theory proposes?  
Mishel (1990) maintains that prolonged uncertainty can be accepted and integrated into one’s life 
and leads to a new view of life or growth through uncertainty. The GTUS provides a measure of 
growth through uncertainty. Scores on the GTUS can range from 39-234 with higher scores 
indicating greater growth through uncertainty. The results for the participants in this study 
ranged from 67-223. The mean score for the participants was 154.6 with a standard deviation of 
29.3. In previous studies of individuals living with continual illness-related uncertainty, 
 50 
 
including breast cancer survivors, parents of children with cancer, and men with prostate cancer, 
the mean GTUS score ranged from 137.40 to 166.00 (see Table 5). The mean GTUS score of 
154.6 in this study falls within the range of mean scores of previous studies with other patient 
populations. Therefore, the answer to the answer to the first research question is: Yes, kidney 
transplant candidates waiting for a deceased-donor transplant do experience growth through 
uncertainty as Mishel describes in her Reconceptualized Uncertainty in Illness Theory.  
Similar to the experience of uncertainty with chronic health conditions, the continual uncertainty 
of waiting for a kidney transplant can lead to a new view of life. 
Relationship among Waiting Time, Level of Uncertainty and Growth through Uncertainty 
The second research question was: What are the relationships among waiting time, level 
of uncertainty and growth through uncertainty for deceased donor kidney transplant candidates?  
Participants in this study had transplant waiting times ranging from 3-180 months with a mean 
waiting time of 37.8 months. The level of uncertainty measured by the MUIS-C ranged from 27-
89 with higher scores indicating greater uncertainty. The scores on the measure of growth 
through uncertainty, the GTUS, ranged from 39-234. Table 6 summarizes these results.  
Pearson correlation coefficients were used to determine the relationships among waiting 
time, level of uncertainty, and growth through uncertainty. These relationships were analyzed for 
the total sample, and the African American and White subsets of the sample. These correlation 
coefficients are reported in Table 7.  
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Table 5 
Growth Through Uncertainty Scale (GTUS) Scores in the Literature 
 
Study n M 
   
Bailey et al. (2004) 49 men with prostate cancer 137.40 (pre-intervention) 
152.10 (post-intervention) 
   
Lin et al. (2010) 301 parents of children with cancer 156.63 
   
Mast (1998) 109 survivors of breast cancer 166.00 
   
Current study 134 deceased-donor kidney  
transplant candidates 
154.6 
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Table 6 
Mean, Standard Deviation, Potential Ranges and Obtained Ranges 
 
Measure n M SD Potential Range Obtained Range 
      
Growth through uncertainty 134 154.6 28.16 39-234 83-226 
      
Waiting Time 134 37.95 28.19 N/A 3-180 months 
      
Level of uncertainty 134 55.85 12.97 23-115 27-89 
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Table 7 
Intercorrelations of MUIS-C, GTUS, and Waiting Time for Total Group (n = 134), African  
 
Americans (n = 103,) and Whites (n = 25) 
 
 Total  African American  White 
 GTUS Wait Time        GTUS Wait Time     GTUS Wait Time 
         
MUIS-C -.06 -.02  -.06 .03  -.12 -.41* 
GTUS    --     .27**         -- .24*         -- .18 
Wait Time  --   --   -- 
Note. *p < .05, **p < .01. 
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A positive relationship was found between waiting time and growth through uncertainty 
for the total population (r = .27, p < .01). Although the strength of this positive relationship is 
classified as low (Munro, 2005), the significance indicates a stable relationship. Other proposed 
relationships between waiting time and level of uncertainty, or between growth through 
uncertainty and level of uncertainty were not significant for the total population. A similar 
relationship between waiting time and growth through uncertainty was found in the African 
American subset (r = .24, p < .05), but no significant relationship between waiting time and 
growth through uncertainty was found in the White subset. Waiting time was inversely related to 
level of uncertainty for Whites (r = .41, p < .05).  
Division into waiting time categories. In order to address the wide range of waiting 
times for the participants in this study, the sample was divided into two groups, those who had 
been waiting less than or equal to the national median waiting time to transplant of 1297 days 
(United States Department of Health and Human Services, Health Resources and Services 
Administration, Organ Procurement and Transplantation Network, 2012) and those who had 
been waiting longer than or equal to the national median waiting time. The median time to 
transplant is from the point of view of a transplant candidate who has just been registered on the 
waiting list for a kidney. Differences in level of uncertainty and growth through uncertainty 
between the two waiting time groups were examined using the Independent-groups t-test. The 
test results, listed in Table 8, indicated a significant difference in the GTUS scores between those 
who had been waiting longer and those who had been waiting less time (p < .001). No      
statistically significant difference in MUIS-C was found between the categories of waiting time 
for the total sample.  
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Table 8 
Independent-groups T-Test for Uncertainty and Growth Through Uncertainty by Waiting  
Time Category 
 
 Total Sample  African American  White 
 n M SD p  n M SD      p  n M SD p 
               
GTUS               
               
≤ MD 86 151.8 25.0   89 159.4 26.5   18 142.83 26.0  
               
>MD 48 170.9 29.5 .000  14 172.9 31.7 .090   7 150.14 38.4 .566 
               
MUISC               
               
≤MD 86 56.0 11.4   89  55.9 12.4   18  57.22 12.9  
               
>MD 48 55.2 15.5 .73  14  57.7 14.2 .743    7  48.00   7.9 .138 
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African American subset. Differences in level of uncertainty and growth through 
uncertainty between the two waiting time categories were examined separately for the large (n = 
103) sample of African Americans in the study. The national median waiting time for a kidney 
transplant for African Americans of 1968 days is longer than the median time to transplant for 
total population of kidney transplant candidates on the wait list for a deceased-donor kidney 
(United States Department of Health and Human Services, Health Resources and Services 
Administration, Organ Procurement and Transplantation Network, 2012). Eighty-nine African 
American participants had been waiting less than or equal to the national median waiting time to 
kidney transplant for African Americans and 14 had been waiting longer than the national 
median time to transplant for African Americans.  
 An Independent-groups t-test was used to compare growth through uncertainty (GTUS) 
and level of uncertainty (MUIS-C) in the two waiting time groups. There are very different 
means for the GTUS in these two groups. The mean for the GTUS for the group with wait times 
at or above the median time to transplant for African Americans was 172.93, while the group that 
had been waiting for less than the median time to transplant had a mean of 159.42. However, the 
sample sizes in the two waiting time groups were widely different (n = 14 and n = 89), leaving 
the researcher to wonder if more participants had been waiting longer than the median time to 
transplant, would the results have reached statistical significance? When level of uncertainty was 
compared for transplant candidates who had been waiting less the median time to transplant and 
transplant candidates who had been longer than 1968 days, no significant difference was found.  
White subset. The median time to transplant for White transplant candidates is 952 days 
(United States Department of Health and Human Services, Health Resources and Services 
Administration, Organ Procurement and Transplantation Network, 2012). When the white subset 
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of participants is considered, no statistically significant relationship between waiting time 
category and level of uncertainty or between waiting time category and growth through 
uncertainty was found for the white participants, although there is a difference in the means for 
the MUIS-C and the GTUS. The total number of White participants was small and the sample 
size was also disparate in this subset with 18 White participants waiting less than the median 
time to transplant and seven in the group that had been waiting at or above the median time to 
transplant.  
Middle Range Theory 
A middle range theory of the relationship among waiting time, level of uncertainty, and 
growth through uncertainty was proposed and tested in this study. It was proposed that: 
1. Deceased-donor kidney transplant candidates show growth through uncertainty as  
      Mishel describes.  
2. The level of uncertainty is related to waiting time in deceased-donor kidney transplant  
          candidates. 
3. Growth through uncertainty is related to both the waiting time and the level of 
     uncertainty experienced by the deceased-donor kidney transplant candidate. 
The first proposition in the middle range theory is supported by the results. The sample of 
kidney transplant candidates in this study demonstrated growth through uncertainty based on the 
results of Mishel’s GTUS. Scores on the GTUS quantify growth through uncertainty with higher 
scores indicating greater growth through uncertainty. The mean score for the sample was 158.66 
out of a maximum of 234. The mean score in this study was within the range of means of other 
studies using the GTUS (Bailey et al., 2004; Lin et al., 2010; Mast, 1998).  
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The second proposition in the middle range theory proposed in the study was not 
supported by the results when considering the total sample. There was no relationship between 
level of uncertainty, which was the score on the MUIS-C, and waiting time. However, when 
considering the White subset, an inverse relationship was found between waiting time and level 
of uncertainty, with longer waiting times associated with lower scores on the MUIS-C. The final 
proposition in the theory stating that growth through uncertainty was related to both waiting time 
and level of uncertainty was partially supported. No relationship between level of uncertainty 
and growth through uncertainty was found. However, there was a significant positive 
relationship (r = .265, p = .002) between waiting time and growth through uncertainty in the 
sample indicating that a longer waiting time for a transplant was associated with greater growth 
through uncertainty (see Figure 4).  
 The findings in this study supported two important propositions in the theory: 
• The sample of deceased-donor kidney transplant candidates demonstrated growth 
through uncertainty, 
• There was a significant positive relationship between waiting time and growth 
through uncertainty in deceased-donor kidney transplant candidates (see Figure 4). 
In addition, among White participants, there was a significant relationship between waiting time 
and level of uncertainty, although, no relationship between waiting time and level of uncertainty 
was found for the total study population. Therefore, support of the proposed relationships was 
mixed. 
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Figure 4. Correlations for the relationships proposed in the middle range theory of the 
experience of uncertainty while waiting for a kidney transplant. 
 
Note. Description of the correlation among growth through uncertainty, waiting time, and level 
of uncertainty proposed in the middle range theory. T = total study population. W = White subset 
of study population. AA = African American subset of the study population. NS = Not 
statistically significant. *p < .05, **p < .01.   
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Summary 
This chapter describes the analysis of data for this study. Descriptive statistics were 
provided for each scale used in the study and for waiting time. The correlation coefficient for 
waiting time, level of uncertainty, and growth through uncertainty was determined to describe 
the relationships among them. The independent-groups t-test was used to compare those whose   
waiting times were longer than the national kidney transplant median waiting time to transplant 
with those whose waiting times were less than or equal to the national median time to transplant. 
Results indicated that deceased-donor transplant candidates experience growth through 
uncertainty as described by Mishel and there was a positive relationship between waiting time 
and growth through uncertainty. The African American subset was analyzed separately and 
waiting time was also associated with growth through uncertainty in this subset. These results 
support an important proposition in the middle range theory proposed in this study.  
 
 
 
 
  
 
CHAPTER V:  DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS 
 Qualitative studies have identified the experience of uncertainty as a key feature of the 
pre-transplant period (Baker & McWilliam, 2003; Brown et al., 2006; Liddle & Innes, 2005; 
Weems & Patterson, 1989) which can be prolonged. According to Mishel’s Reconceptualized 
Uncertainty in Illness Theory, continued uncertainty associated with chronic illness can lead to 
growth through uncertainty and a new view of life (Mishel, 1990). The purpose of this study was 
to further describe the experience of uncertainty during the wait for a transplant, which will help 
identify patient needs and contribute to the development of nursing interventions to improve the 
nursing care of this growing population. A middle range theory was tested that proposes that 
deceased-donor kidney transplant candidates show growth through uncertainty as described by 
Mishel (1990). Since nurses are structure providers within this theoretical framework, they can 
help transplant candidates appraise illness-related uncertainty as opportunity rather than danger. 
The relationships among waiting time, level of uncertainty, and growth through uncertainty were 
explored to provide further understanding of the experience of uncertainty in deceased-donor 
kidney transplant candidates. A descriptive survey research design was used to address the 
following research questions:   
 1. Do deceased donor kidney transplant candidates experience growth through  
          uncertainty as defined by Mishel? 
 2. What are the relationships among waiting time, level of uncertainty and growth   
     through uncertainty for deceased donor kidney transplant candidates?   
The discussion of the findings, conclusions, and recommendations are presented in this chapter.  
Discussion 
 The purpose of this study was to describe the experience of uncertainty in deceased-
donor kidney transplant candidates through testing of a middle range theory that proposes that: 
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 1. Deceased-donor kidney transplant candidates show growth through uncertainty as  
                Mishel (1990) describes. 
 2. The level of uncertainty is related to waiting time in deceased-donor kidney transplant  
     candidates. 
       3. Growth through uncertainty is related to both the waiting time and the level of 
                uncertainty experienced by the deceased-donor kidney transplant candidate. 
 Personal growth in response to living with sustained uncertainty has been proposed in the 
literature (Mishel, 1990; Penrod, 2007). As noted in the first proposition of the middle range 
theory, Mishel has described growth through uncertainty in chronic illness, and the GTUS was 
developed to quantify growth through uncertainty. Although growth through uncertainty has 
been described for chronic conditions such as in men with prostate cancer (Bailey et al., 2004)   
and in breast cancer survivors (Mast 1998; Porter et al., 2006), the question of whether or not 
deceased-donor kidney transplant candidates appraise uncertainty as an opportunity and develop 
a new view of life that no longer includes an expectation of predictability had not been 
addressed. The questioning of the experience of growth through uncertainty in transplant 
candidates stemmed from descriptions of the pre-transplant period in the literature as being a 
time when “life was on hold” (Moran et al., 2011) or likened to “walking in the dark” (Weems & 
Patterson, 1989), but also could be a time of transformation (Brown et al., 2006). Was the 
appraisal of uncertainty while enduring this wait and hoping for a transplant to lead to greater 
well-being different than the appraisal of uncertainty in chronic illness, when uncertainty may be 
preferred to confirmation that one’s condition is worsening? When tested in this study, deceased-
donor kidney transplant candidates did experience growth through uncertainty, indicating that 
they respond to the ongoing uncertainty during the wait for a transplant by integrating 
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uncertainty into their life and creating a new view of life, which Mishel labeled growth. 
Although the mean for the GTUS in this study fell within the range of means for previous studies 
using the GTUS (Bailey et al., 2004; Lin et al., 2010; Mast, 1998), the scores for the GTUS in 
this study ranged from 83-226, indicating that some deceased-donor kidney transplant candidates 
experienced more growth through uncertainty than others.  
    The second proposition proposes that deceased-donor kidney transplant candidates 
have different levels of uncertainty associated with different waiting times for a transplant. 
Brashers et al. (2003) suggest that appraisal of illness-related uncertainty may vary over time. 
Findings in qualitative research have suggested: The stressors and the experience of uncertainty 
change during the wait for a transplant (Brown et al., 2006; Corruble et al., 2010; Evangelista et 
al., 2005; Moran et al., 2011; Weems & Patterson, 1989); there are different responses to 
different pre-transplant waiting times (Brown et al, 2006;  Moran et al., 2011; Weems & 
Patterson, 1989) and there is a need for further description of uncertainty pre-transplant, 
especially in relation to waiting time (Brown et al., 2006; Cupples et al.,1998; Martin et al., 
2010;  Stoeckle, 1993). The present study measured uncertainty in deceased-donor kidney 
transplant candidates and explored the relationship between waiting time and level of 
uncertainty. Overall, the level of uncertainty reported by deceased-donor kidney transplant 
candidates in the present study did not vary based on waiting time. However, when the subset of 
White transplant candidates was considered, uncertainty decreased as the waiting time increased. 
The mean waiting time for the White participants of 25 months was less than the mean waiting 
time of almost 38 months for the total sample in the study, raising the question of whether, 
initially, uncertainty decreases as waiting time increases, but, at some point, as waiting time 
increases, the level of uncertainty experienced by kidney transplant candidates becomes more 
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variable. Lasker, Sogolow, Olenik, Sass, and Weinrieb (2010) found that uncertainty in women 
waiting for a liver transplant was related to fatigue, depression, fear/anxiety, and satisfaction 
with Information while on the waiting list. Other factors may have a greater correlation with 
level of uncertainty in deceased-donor kidney transplant candidates than waiting time.  
The third relationship proposed in the middle range theory in this study was that growth 
through uncertainty is related to waiting time and to level of uncertainty in deceased-donor 
kidney transplant candidates. Bailey and Nielson (1993) found higher levels of uncertainty may 
lead to appraisal of uncertainty as a threat rather than an opportunity. The proposed relationship 
suggests that transplant candidates who are more uncertain do not experience the same amount of 
growth through uncertainty as those who are less uncertain. No significant relationship between 
the level of uncertainty for deceased-donor kidney transplant candidates and growth through 
uncertainty was found in this study. Similarly, Lin et al. found that parental uncertainty did not 
have a significant direct effect on growth through uncertainty in Taiwanese parents of children 
with cancer. Perhaps level of uncertainty needs to be considered in combination with other 
factors when examining the relationship of uncertainty to growth through uncertainty in 
transplant candidates. Lin et al. (2010) found that coping mediated the effect of parental 
uncertainty on growth through uncertainty. In their study of breast cancer survivors, Porter et al. 
(2006) constructed a variable labeled “negative cognitive state” consisting of uncertainty, 
troublesome thoughts, and castastrophizing, which was a significant predictor of personal 
growth.  
The relationship between waiting time and growth through uncertainty was also explored 
in this study. Living longer with uncertainty may be associated with how uncertainty is appraised 
(Bailey & Nielsen, 1993; Mishel, 1990). This study demonstrated that a longer waiting time is 
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related to greater growth through uncertainty in deceased-donor kidney transplant candidates, 
which supported an important proposition in the middle range theory proposed in this study. 
While various factors can influence the appraisal of uncertainty, the relationship between waiting 
time and growth through uncertainty in this study builds support for Mishel’s Reconceptualized 
Uncertainty in Illness Theory which proposes that continued uncertainty, such as waiting for a 
transplant, may lead to a new view of life (Mishel, 1990).  
Uncertainty has been identified as a pervasive characteristic of the wait for a transplant in 
qualitative studies (Baker & McWilliam, 2003; Brown et al., 2006; Liddle & Innes, 2005; 
Weems & Patterson, 1989). The description of uncertainty and growth through uncertainty for 
deceased-donor kidney transplant candidates in this study builds on the qualitative studies that 
have focused on the experience of waiting for a transplant. The study adds to the description of 
uncertainty pre-transplant through quantitatively describing the relationship between uncertainty 
and waiting time and the experience of growth through uncertainty in deceased-donor kidney 
transplant candidates. Studies that focus on the pre-transplant period are limited in the literature. 
The results of this study expand what is known about the experience of waiting for a transplant. 
A descriptive survey research design was used to explore the relationships among waiting 
time, level of uncertainty, and growth through uncertainty in this study. The modifications in 
methodology that were necessary to implement this study may provide some insight into 
reaching the population of kidney transplant candidates in the community. Each change in 
strategy to recruit participants required UMIRB approval. Initially, recruitment of participants 
was a struggle. Fliers posted at dialysis clinics and messages on a National Kidney Foundation 
Message Board recruited less than a tenth of the overall number of participants. Ultimately, a 
mailed survey was the most effective means to reach the deceased-donor kidney transplant 
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candidates. Over 50% of the transplant candidates actively waiting for a deceased-donor kidney 
at a transplant center responded when the survey was mailed to them. Mailing the survey through 
the transplant center may have added to the credibility of the study.  
The majority of the transplant candidates at the transplant center that mailed the survey 
are African American and most of the participants in the study are African American. Patients 
with ESRD who are African American are less likely to be on the wait list for a kidney 
transplant, although the African American population has a higher incidence of ESRD (Hall et 
al., 2011). African Americans comprise approximately 14% of the population in the United 
States (U.S. Department of Commerce, United States Census Bureau), but about 37% of kidney 
transplant candidates are African American [Organ Procurement and Transplantation Network 
(OPTN) and Scientific Registry of Transplant Recipients (SRTR)]. Once on the wait list for a 
kidney transplant, African Americans wait longer for a transplant. The description of growth 
through uncertainty and the relationships among waiting time, level of uncertainty and growth 
through uncertainty for the large subset of African Americans in this study provides additional 
information on the experience uncertainty while waiting for a transplant in this more vulnerable 
population.  
  The instruments (MUIS-C and GTUS) were reliable for the sample in this study.  
The MUIS-C has been more extensively used in research measuring uncertainty in various 
populations (Mishel, 1997). The GTUS has been used in few studies, but the growth through 
uncertainty found in the study sample falls within the range of means of other studies using the 
GTUS. However, further research may consider questions that are uniquely crafted for the pre-
transplant period.  
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The methodology of this study has both strengths and limitations. The sample size 
contributed to the strength of the analysis in this study. These findings are specific to the 
deceased-donor kidney transplant candidates in the study and are not generalizable to other types 
of organ transplants.  
Mishel’s Reconceptualized Uncertainty in Illness Theory was the framework for this 
study. From Mishel’s theory a middle range theory was proposed and tested. A key proposition 
of the middle range theory was that deceased-donor kidney transplant candidates experience 
growth through uncertainty as Mishel describes. This proposition was supported which allowed 
for testing the proposed relationship among growth through uncertainty, waiting time and level 
of uncertainty.    
Conclusions 
 Waiting for a transplant implies uncertainty; the unknown of when or if an organ will 
become available. Transplant candidates appraise and respond to uncertainty in the liminal space 
between the promise of a transplant and the threat of death which affects their well-being during 
the wait for a transplant (Brown et al., 2006; Molzahn et al., 2008). The description of 
uncertainty experienced by deceased-donor kidney transplant candidates in this study builds on 
qualitative research that identified uncertainty as a theme of the pre-transplant period. Previous 
studies on the experience of waiting for a transplant noted differences related to waiting time 
(Brown et al., 2006; Cupples et al., 1998; Evangelista et al., 2005; Martin et al., 2010; Stoeckle, 
1993). This study specifically focused on waiting time, describing the relationship among 
waiting time, level of uncertainty and growth through uncertainty. 
Mishel (1990) contends that continued illness-related uncertainty can lead to growth 
through uncertainty. The findings of this study support Mishel’s Reconceptualized Uncertainty in 
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Illness Theory that a new view of life can evolve when sustained uncertainty is experienced. For 
the deceased-donor kidney transplant candidates in this study, greater growth through uncertainty 
was associated with longer waiting time. Therefore, the present study contributes to the 
development of the theory of uncertainty in illness through describing the growth through 
uncertainty experienced by deceased-donor kidney transplant candidates and the relationship 
between waiting time for a transplant and growth through uncertainty. Studies based on Mishel's  
Reconceptualized Uncertainty in Illness Theory have considered growth through uncertainty in 
chronic conditions such as prostate cancer, childhood cancer, and breast cancer (Bailey et al., 
2004; Lin et al., 2010; Mast, 1998). There was no prior research in the literature on the 
measurement of growth through uncertainty in kidney transplant candidates and limited research 
on the experience of uncertainty pre-transplant in Nursing and other health care literature. The 
present study extends understanding of sustained uncertainty in illness.  
Nurses and other health care providers, who are conceptualized as structure providers in 
Mishel’s Reconceptualized Uncertainty in Illness Theory (Bailey & Stewart, 2010; Mishel, 1990; 
Mishel & Clayton, 2008), may influence the appraisal of uncertainty by transplant candidates. 
Appraising the uncertainty associated with waiting for a transplant as an opportunity rather than 
a threat may improve the well-being of the transplant candidate. Expanding the care of transplant 
candidates to include consideration of how they appraise uncertainty associated with the 
unpredictable wait for a transplant may encourage the development of interventions to help 
transplant candidates incorporate the uncertainty into a new view of life.  
Recommendations 
 The findings of this study suggest several areas for further research:  
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• Are there factors other than waiting time associated with growth through uncertainty 
in transplant candidates?   
• How can the role of structure providers within the theoretical framework, including 
nurses, be expanded to support transplant candidates? 
• Since the uncertainty related to when or if a transplant will occur cannot be 
eliminated, how can transplant candidates be supported while they are waiting for a 
transplant?   
• What nursing interventions might be developed for helping transplant candidates to 
incorporate sustained uncertainty into a new view of life?   
Some qualitative studies have considered the experience of waiting for a transplant for 
family members and support persons (Mishel & Murdaugh, 1987; Pelletier-Hibbert & Sohi, 
2001; Saxe-Braithwaite & Chapman, 1992; Starzomski & Hilton, 2000). Mishel’s 
Reconceptualized Uncertainty in Illness Theory proposes that support persons influence 
appraisal of uncertainty (Bailey & Stewart, 2010; Mishel, 1990; Mishel & Clayton, 2008). 
Further study is needed on how caregivers or support persons may influence the experience of 
uncertainty and growth through uncertainty pre-transplant. Nurses and other health care 
providers can then consider interventions that include consideration of support persons. 
Essentially, ongoing research needs to add to the understanding of the experience of waiting for a 
transplant and lead to changes in care that will provide more support to those who wait. 
In this study, growth through uncertainty was positively related to waiting time for 
transplant candidates. Research to look more specifically at waiting time and differences in the 
appraisal of uncertainty may help tailor nursing interventions that will provide greater support to 
transplant candidates. A study sample that has a more equal distribution of waiting times and 
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includes more transplant candidates who have been waiting longer than the median time to 
transplant would provide more specific information related to waiting time. A longitudinal study 
would allow for assessing how a transplant candidate appraises uncertainty over time. The 
instruments used in this study have been used to measure uncertainty and growth through 
uncertainty with individuals with a variety of chronic health conditions. Development of tools 
specific to transplant candidates may be a means to assess the experiences of transplant 
candidates during the wait and may be designed to help identify the support that a transplant 
candidate may want from health care providers.  
Comments were not solicited from participants, but, when comments were volunteered 
by a participant they were noted. The comments were anecdotal related to their experience or 
were in response to a particular item on the GTUS or MUIS-C. Fewer than 10% of the 
participants commented, but the comments may provide some insight into areas for further 
research. Some of the comments volunteered by participants (see Appendix L) relate to 
maintaining hope during the wait for a transplant. Transplant candidates may wonder if they will 
ever be called to receive a transplant and getting through each day may mean continuing to hope 
that the call will come. Some participants described praying and trusting in God to help them 
during the wait for a transplant. These comments suggest that spirituality and the ability to 
remain hopeful may affect how uncertainty is appraised. One participant suggested that more 
communication with the transplant center and more knowledge of successful transplants may 
help preserve hope. Previous studies have considered hope, coping or spiritual well-being in 
relation to the experience of uncertainty (Anema et al., 2009; Lin et al., 2010; Weems & 
Patterson, 1989). Future studies of the experience of waiting for a transplant should consider 
what influences how a transplant candidate responds to the uncertainty including:  
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• What coping strategies do transplant candidates use during the wait for a transplant?  
Do coping mechanisms change as waiting time increases?  How are coping strategies 
related to the experience of uncertainty and growth through uncertainty? 
• What is the relationship among spirituality, waiting time, uncertainty, and growth 
through uncertainty? 
• What interactions with nurses and other health care providers facilitate hope and 
coping during the wait for a transplant? 
            The large African American subset in this study reflects the higher number of African 
Americans who are waiting for a kidney transplant. Although, not the purpose of this study, 
based on the suggestion by Brown et al. (2006) that different cultural beliefs about time and 
illness may lead to different experiences of time pre-transplant, the unique experiences of this 
population during the wait for a transplant need further description.  
• How is the experience of African American deceased-donor kidney transplant 
candidates different?  
• Are different types of intervention needed to support African Americans as they wait 
for a transplant and/or is support needed at different times?  
Exploring the relationship between demographic factors, such as age, education, and marital 
status, and uncertainty and growth through uncertainty may also increase understanding of the 
experience of uncertainty while waiting for a transplant. 
Summary 
This chapter discusses the findings of this study, the conclusions drawn from this 
study, and recommendations for further study. The findings of this study extend nursing 
knowledge through providing further understanding of the appraisal of uncertainty in deceased-
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donor transplant candidates. An important proposition of the middle-range theory proposed in 
this study was supported by the findings, which builds support for Mishel’s Reconceptualized 
Uncertainty in Illness Theory. The results also provide direction for future research focused on 
describing other factors that influence growth through uncertainty in transplant candidates and 
the development of nursing interventions that facilitate the integration of uncertainty into a new 
life view and offer support during the wait for a transplant. 
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APPENDIX C: DEMOGRAPHIC FORM 
  
 
 
 
 
 
 
 
 
 
 
In order to analyze the information that you are providing, some information about your 
personal background is needed. 
 
1. How long have you been on the wait list for a kidney transplant?     
       
       ______years   ______months 
 
 
2. Type of dialysis: 
          Hemodialysis                   Peritoneal                    None 
 
 
3. How old are you? __________ 
                                 (age in years) 
 
4. Gender:       Male           Female 
 
 
5. Race/Ethnicity:  (Please check one) 
 
  African American     Asian/Pacific Islander     Hispanic/Latino   
 
  White     Other_________________ 
                               (please specify) 
 
 
6. Marital status:    Married     Divorced     Widowed     Single    Living with partner 
 
 
7. Number of years of education:____________________________________ 
 
IF YOU WANT TO MAIL THE SURVEY, PLEASE COMPLETE 
ALL PAGES OF THE SURVEY AND MAIL IN THE STAMPED 
ENVELOPE THAT IS ENCLOSED. FILL IN THE CARD WITH 
YOUR NAME AND ADDRESS AND PLACE IT IN THE 
ENVELOPE WITH THE SURVEY SO THAT YOU CAN RECEIVE 
$10.00 TO THANK YOU FOR YOUR PARTICIPATION. OR, YOU 
CAN JUST CALL THE TOLL FREE NUMBER, 1-877-719-9910, TO 
COMPLETE THE SURVEY BY PHONE. 
 
  
 
APPENDIX D: MISHEL UNCERTAINTY IN ILLNESS SCALE  
     (Community) SAMPLE 
                                  Do not administer. 
        INSTRUCTIONS: 
          Please read each statement. Take your time and think about what each statement  
          says. Then place a “X” under the column that most closely measures how you  
          are feeling  TODAY. If you agree with a statement, then you would mark under 
          either “Strongly Agree” or “Agree”. If you disagree with a statement, then mark  
          under either “Strongly Disagree” or “Disagree”. If you are undecided about how you  
          feel, then mark under “Undecided” for that statement. Please respond to every  
          statement. 
 
1. I am unsure if my illness is getting better or worse. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
2. The doctors say things to me that could have many meanings. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
3. It is difficult to know if the treatments or medications I am getting are helping. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
4. Because of the unpredictability of my illness, I cannot plan for the future. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
5. The seriousness of my illness has been determined. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
(http://nursing.unc.edu/ccm/groups/public/@nursing/documents/content/ccm3_032880.pdf) 
  
 
APPENDIX E: GROWTH THROUGH UNCERTAINTY SCALE SAMPLE 
I am interested in learning how your view of life has changed as a result of living with the 
uncertainty of waiting for a transplant. The statements below describe feelings people sometimes 
have in the period following an illness. For each item, circle the response that best describes 
your feelings TODAY. Please make sure that you answer every item.  There are no right or 
wrong answers. 
 
 My life has new 
meaning. 
6 5 4 3 2 1 
 
 Strongly 
Agree 
Moderately 
Agree 
Agree Undecided Disagree Strongly 
Disagree 
D1 My situation has opened 
new possibilities for me. 
Strongly 
Agree 
Moderately 
Agree 
Agree Undecided Disagree Strongly 
Disagree 
D2 I greet each day with 
more joy. 
Strongly 
Agree 
Moderately 
Agree 
Agree Undecided Disagree Strongly 
Disagree 
D3 I fear the unexpected 
more now.  
Strongly 
Agree 
Moderately 
Agree 
Agree Undecided Disagree Strongly 
Disagree 
D4 My dreams are clearer 
to me now. 
Strongly 
Agree 
Moderately 
Agree 
Agree Undecided Disagree Strongly 
Disagree 
D5 I focus more now on 
what is important in life.  
Strongly 
Agree 
Moderately 
Agree 
Agree Undecided Disagree Strongly 
Disagree 
 
 
 
 
 
 
 
 
 
 
  
 
APPENDIX F: STUDY FLIER 
 
 
 
 
 
 
  
 
APPENDIX G: TELEPHONE SCRIPT 
Telephone Script 
 
Thank you for calling about my research study. I am a nurse and a doctoral student at East 
Carolina University. I will be talking with you to learn more about your experiences while 
waiting for a transplant.  
 
I will be asking you a series of questions. 
 
It will take about 30 minutes. 
 
I will read a sentence to you and you will answer by telling me if you agree or disagree. 
 
There are no right or wrong answers since this is about how you feel. 
Your answers will be confidential and will be kept in a locked file 
Your name is not used and you will not be personally identified. 
I will ask for your mailing address only for sending you $10.00 to thank you for participating. I 
will not be keeping this information. 
 
You can ask questions about the study and you may stop at any time. 
You may contact me at this toll free number and I will send you information on how to contact 
my advisor at East Carolina University in case you have questions about the research.  
Do you have any questions about what I am asking you to do? 
Do you have any questions about the confidentiality of the information you are giving me?  
Do you have any other questions? 
If you are ready, I would like to start with the first question. 
 
 
 
 
 
 
 
 
 
 
  
 
 
APPENDIX H: LETTER FROM TRANSPLANT CENTER 
  
 
We are sending you this letter on behalf of Janet Pelletier, RN, FNP-BC, a doctoral 
candidate in nursing at East Carolina University. She is conducting a study of people 
who are waiting for a kidney transplant. Your name or contact information has not been 
given out. We are giving you the opportunity to participate in her study. The survey 
takes about 20 minutes to complete by phone or you can mail the survey. Your 
responses are confidential and are not associated with your care at the transplant clinic. 
She will send you ten dollars in appreciation of your participation.  
 
We understand that the wait for a transplant can be trying. This study is designed to 
provide information to improve care for transplant candidates. We hope you will agree to 
participate by calling 1-877-719-9910 or by completing the survey provided with this 
letter.  
 
Sincerely, 
 
 
 
Transplant Coordinator 
  
                                                                                                                                        
    
 
 
 
 
 
 
 
 
 
 
  
  
 
APPENDIX I: LETTER TO PARTICIPANTS FROM RESEARCHER 
Dear Participant, 
 
I am a doctoral candidate at East Carolina University in the College of Nursing. I am asking you 
to take part in my research study entitled, “Appraisal of Uncertainty While Waiting for a Kidney 
Transplant.”  
 
The purpose of this study is to learn more about uncertainty while waiting for an organ 
transplant. By doing this research, I hope to increase understanding of the experience of waiting 
for a transplant to  help identify patient needs and guide research to improve nursing care of 
transplant candidates. Your participation is voluntary.  
 
You are being invited to take part in this study through the transplant clinic because you are 
waiting for a kidney transplant. The amount of time it will take you to complete this study is 
about 20-30 minutes. You are being asked to complete a survey by phone or by mail, which will 
involve answering multiple choice questions about how you are feeling.  
 
Because this research is overseen by the ECU Institutional Review Board, some of its members 
or staff may need to review my research data. However, the information you provide will not be 
linked to you in any way. I will ask for your mailing address to send you the $10.00 in 
appreciation of your participation, but your name will not be associated with your responses on 
the survey.  
   
If you have questions about your rights as someone taking part in research, you may call the 
UMCIRB Office at phone number 252-744-2914 (days, 8:00 am-5:00 pm). If you would like to 
report a complaint or concern about this study, you may call the Director of UMCIRB Office, at 
252-744-1971.  
 
You do not have to take part in this study, and you can stop at any time. If you are willing to 
participate, call me toll free at 1-877-719-9910. Please leave a message with how and when I 
may contact you if I am unable to take your call. If you prefer to complete the survey by mail, it 
is enclosed. 
 
Thank you for taking the time to participate in my study. 
 
Sincerely, 
 
 
Janet Pelletier, Principal Investigator 
 
  
  
 
APPENDIX J: REMINDER POSTCARDS 
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APPENDIX K: LETTER TO PARTICIPANTS FOLLOWING PARTICIPATION  
IN THE STUDY 
 
 
Janet Pelletier, PhDc, RN, FNP-BC 
Doctoral Candidate 
East Carolina University College of Nursing 
P.O. Box 707 
Bridgeton, North Carolina  28519 
 
 
 
Thank you very much for participating in my research study and sharing your experiences about 
waiting for a kidney transplant!  Ten dollars is enclosed with this letter in appreciation of your 
participation. If you have any questions about the study or would like to receive a summary of 
study results, you may contact me by mail or at my toll free telephone number. The number is 1-
877-719-9910 and my e-mail address is: pelletierj04@students.ecu.edu. You may also contact 
my faculty advisor: Martha Raile Alligood, PhD, RN, ANEF, Professor, East Carolina 
University College of Nursing, Health Sciences Building, Greenville, NC 27858-4323. Her 
telephone number is 252-744-6416. 
 
Questions related to your care or waiting for a transplant, should be directed to your health care 
provider or transplant coordinator. 
 
Thank you again for taking the time to participate in the study. You are greatly appreciated and I 
wish you well.  
 
 
Sincerely, 
 
 
 
Janet Pelletier, PhDc, RN, FNP-BC 
 
 
 
 
 
 
 
 
 
 
 
  
 
APPENDIX L: PARTICIPANT COMMENTS 
 
These questions are really more for people who were recently listed;” 
“I was never upset at little things- I don’t worry.”  (Waiting 4 years). 
 
“Some of the questions I don’t know how to ask.”  (Waiting 5 years, 11 months). 
“I know it’s getting worse;”  “Everything changes;” When you are sick, you always have to 
challenge yourself more.”   (Waiting 2 years). 
“My wife just died two months ago so that affects how I answer some of the questions;” “My 
(sibling) will not donate a kidney.”  (Waiting 3 years).  
“I have “dialysis head” and feel loopy some of the time.”   (Waiting 11 months). 
“I have lots of trust in God;”  “It will happen if it is meant for me;”  “It would break my heart to 
do worse after the transplant than I have been doing day by day for the past 15 years, but it could 
make my life better;”  “I have never let it pull me down-I try to stay active-I have a lot of 
buddies.”   (Waiting 15 years).  
“I can get out and do what I want and when;”  “Sitting back and dwelling on things is the last 
thing I am gonna do- it makes things look bad;”  “I’m better off than I would be without a chance 
for a transplant;”  “I’m not changing-things have a way of working out-a lot of things are worse- 
I’ve got to make the best of the situation.”  (Waiting 8 months) 
“I’m trying to be positive;” “I’m not afraid, but I do think about the outcome;”  “It’s a second 
chance-I’m doing good on dialysis, but I don’t want to be on it all my life;”  “I take one day at a 
time,”  “Even though I have this situation, I have the same values,”   “My outlook is more 
positive since waiting for a transplant-a chance to be off dialysis.” (Waiting 3 years, 1 month)  
“I’m glad to still be living;”  “Everything has changed in my life, I have to eat right and do 
right;”  “I don’t have no choice (but to go with the flow);”   “It has changed my life;”  “I have to 
have joy in my heart;”  “I know I have to go to dialysis so I don’t mind doing it;”  “It’s for my 
health so I don’t mind being told what to do;”  “I love to travel and I can’t travel-you have to pay 
for dialysis when you travel;”  “Sometimes (I am more afraid of how I will end up)- I try to keep 
positive that things will get better-that I will get a kidney.”  (Waiting 2 years 3 months) 
“I know I’m getting worse.”  (Waiting one year). 
“I was doing better a year ago;” “The medications and dialysis are helping;”  (Described having 
more problems during dialysis)-“I am not sure I will make it through dialysis;” “If I get a kidney, 
my future is clearer;” “It gives you hope-It will be a little better when you get a kidney;”  
“Thinking that I might get a call helps me get through the day,”  “I can be active the morning 
after dialysis-  I get full of fluid and don’t want to be around other people-I’m weak on the day I 
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have dialysis;”  “My appearance has changed-I get short of breath from the fluid;” “I’m able to 
spend less time with others;”  “I am hoping for the best;”  “I try not to worry;”  “Praying helps;”  
You have to work with the time you feel good;”  “My hopes are the same;”  “I still expect a 
kidney-that’s what keeps me going.”  (Waiting 2 years). 
“They never talk about transplants at the dialysis clinic;”  “There needs to be more 
communication from the transplant clinic;”  If you hear about successes, you have more hope-at 
least there’s hope;  “People need to be more comfortable talking about transplants;”   “There 
needs to be more education in the black community about what it (a transplant) is- If there were 
more education in the community, people would be more receptive to organ donation;” “Patients 
on dialysis need to have a means of communication (with the transplant clinic)”  (Waiting 3 
years) 
“Dialysis is a different way of life that few could even imagine. Filled with some very sick 
people, the dialysis centers are filled with the sights, sounds and smell of death and dying 
alongside those who are trying to keep their world from unraveling. My personal philosophy has 
been to make the best of a very grim and sobering reality of ESRD. The worst part of wait time 
for transplants is what I refer to as “donor apathy.” In my personal situation, I have campaigned 
for donors locally and statewide; however, my impression is that donors will choose to donate if 
they have strong personal feelings or if they are hit squarely in the face with a relative or close 
friend who needs a kidney. In my personal situation, I was initially excited about the possibility 
of a donor. In time, the excitement would end. I actually became conditioned to life with 
dialysis---or not.  
During this time, I became somewhat frustrated at not having an idea of my relative standing or 
if I would ever be called. In the meantime, I delivered two eulogies and attended several funerals 
while simultaneously doing everything I could to be compliant and stay as healthy as I could. 
The wait became so iffy in my view that I had actually dismissed the possibility of a real 
donation. Fortunately, I was incorrect in my view when I received a call this week. Hopefully, 
there will be more.”   (Submitted in writing and mailed to the researcher by a participant) 
 
 
